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Abstract
From inner segment to outer segment: Palmitoylation of photoreceptor Na+, K+ATPase and the importance of PRCD in photoreceptor outer segment
morphogenesis
Emily R. Sechrest
Photoreceptors are specialized neuroepithelial cells which are optimized for efficient
capture of light and initiation of visual transduction. These cells have several
compartments which are very important for proper visual function and segregation of
cellular processes, including the outer segment (OS), inner segment (IS), nucleus, and
synapse. The IS houses all of the cellular organelles and biosynthetic molecular
machinery the cell requires and is the site of protein synthesis. The light-sensing OS is a
highly modified, primary cilium, which contains many stacks of double membranous discs
which house proteins required for formation and maintenance of OS structure, as well as
phototransduction. These structural and phototransduction proteins are synthesized in
the IS and subsequently trafficked to the OS through the narrow connecting cilium. Many
of these proteins undergo post-translation lipid modifications for proper subcellular
localization and association with the OS disc membranes. While the proteins involved in
the phototransduction cascade are crucial for generating signals of vision, regulation of
the photocurrent is needed for proper depolarization and hyperpolarization of the
photoreceptor neuron, a process which is required for the cell to transduce electrical
impulses to downstream neurons. Many ion channels, exchangers, and pumps, including
the CNG channels and the NCKX in the OS, as well as the Na+, K+-ATPase and the HCN
channel in the IS, are involved in this process of maintaining the photocurrent in both dark
and light. One small OS disc-specific protein whose function has not yet been elucidated
is progressive rod-cone degeneration, or PRCD. Previous studies in our lab have
identified that PRCD is post-translationally lipid modified by S-palmitoylation on its sole
cysteine, which is required for its stability and localization to the OS. Though PRCD has
been shown to be important in OS disc morphogenesis and maintenance, its specific role
in this process remains unclear. In this dissertation, I utilize a Prcd-KO animal our lab
generated using CRISPR/Cas9 genome editing in order to investigate photoreceptor
function, OS ultrastructure, and rhodopsin packaging into disc membranes in the absence
of PRCD. Furthermore, I utilize acyl resin-assisted capture and mass spectrometry in
order to identify novel proteins in the retina which undergo S-palmitoylation and validate
palmitoylation profiles of several proteins using additional well-established techniques in
the field. In Chapter 1 of this dissertation, I review the functional and structural needs of
photoreceptor neurons, as well as the roles of both PRCD and the b2-subunit of the retinal
Na+, K+-ATPase (ATP1B2) in these requirements. In Chapter 2, I characterize the
functional and structural consequences of loss of PRCD in our lab-generated Prcd-KO
mouse model, demonstrating through atomic force microscopy (AFM) analysis the role
PRCD plays in regulation of rhodopsin incorporation into OS disc membranes. In Chapter
3, I use various techniques to reveal and validate that the ATP1B2 is palmitoylated on its
N-terminal cysteine at the 10th amino acid (Cys10). Finally, in Chapter 4, I discuss the
results and conclusions of my dissertation work and propose experiments to further

investigate the specific role of PRCD in photoreceptors and the importance of
palmitoylation of ATP1B2 in the retina. Elucidation of the specific role PRCD plays in disc
morphogenesis and investigation of its interaction with rhodopsin will help to further the
field and provide a deeper look into how discs are formed and maintained. Further
investigation of the role palmitoylation plays in ATP1B2 function will help to establish the
unique requirement of expression of ATP1B2 in the retina and identify new roles for
ATP1B2 in cells where it is expressed.
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Chapter 1 – Review of the Literature
1.1 The Vertebrate Retina
Visual perception is initiated in the retina, a 200 µm-thick tissue located at the very back
of the eye1. Light enters the eye through the pupil, which dilates or constricts in order to
control the amount of light which enters the eye2. Once light reaches the retina, a series
of electrochemical events are triggered, resulting in conversion of light into electrical
impulses3. These impulses are subsequently transduced from the retina to the optic nerve,
and then to the brain for visual processing within the visual cortex1.

The vertebrate retina is a highly laminated structure, with the cell bodies and processes
of each retinal cell type segregated into alternate layers1,3-6. The outermost cells in the
retina (those closest to the back of the eye) are the photoreceptor neurons, which are
specialized neuroepithelial cells7. Photoreceptors are responsible for capturing photons
of light and converting those stimuli into electrical impulses which are sent to downstream
neurons1,3-5. The nuclei of photoreceptors are located in an anatomical region termed the
outer nuclear layer (ONL). The cell bodies of inner retinal neurons (bipolar, amacrine, and
horizontal cells) collectively form the inner nuclear layer (INL). Finally, the ganglion cell
layer (GCL) occupies the innermost part of the retina. The synapses of photoreceptors
contact bipolar and horizontal cell dendrites in the outer plexiform layer (OPL). Meanwhile,
the inner plexiform layer (IPL) connects bipolar, amacrine, and ganglion cells (Fig. 1.1)1,5,6.

1

Figure 1.1. The vertebrate retina. A cross-section of the eye (left) shows the anatomical
locations of several important visual structures. A white square is enlarged to depict the
laminar structure of the retina (right), with the RPE at the outermost portion of the retina
and the ganglion cell layer at the innermost region of the retina.
In addition to the aforementioned cell types, Müller glia are also present in the vertebrate
retina and have been shown to be important modulators of retinal homeostasis8. Müller
glia, whose cell bodies reside within the INL, have processes which span the entire
thickness of the retina9. This feature enables Müller glia to support the structural integrity
of the retina8. Additionally, Müller glia help to form the outer limiting membrane (OLM)
and inner limiting membrane (ILM)10.

Adherens junctions between Müller glia and

photoreceptor inner segment (IS) comprise the OLM, which is a functional barrier that
separates the subretinal space and the neural retina8,11. An additional barrier is formed
by the ILM to separate the vitreous from the inner retina and it is formed by Müller glia
endfeet and astrocytes8. Behind the neural retina exists a pigmented layer of cells known
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as the retinal pigmented epithelium (RPE), which are responsible for several different
processes that are crucial to vision, but also help to absorb any scattered light which is
not absorbed by the photoreceptor neurons4.

1.2 Photoreceptors
The vertebrate retina contains two general types of photoreceptors, rods and cones,
which assume different functional roles in vision. In most vertebrate species (including
humans and primates), rods comprise ~95% of photoreceptors and cones make up the
remaining ~5%12. Notably, rods are extremely sensitive to light and can be stimulated
by single photons of light, allowing them to function in predominantly dim light conditions.
Cones, on the other hand, are much less sensitive to light and therefore are actively
utilized in bright or daylight conditions3.

The molecular machinery which gives photoreceptors their light-sensing ability is
comprised of the apoprotein opsin and its bound chromophore, 11-cis-retinal13. In rods,
there is only one version of this light-sensing machinery, termed rhodopsin. Rhodopsin
protein plays a crucial role in both the functional abilities and structural integrity of the rod
photoreceptor14. In contrast to rods, cones possess multiple opsins, though the exact
number depends on the species15. In humans, there are three types of cone opsin,
allowing for color differentiation. These different cone opsins are sensitive to either short
(S), medium (M), or long (L) wavelengths of light and are therefore dictated as S-, M-, or
L-cones16,17.

3

1.2.1 Photoreceptor Structure
Photoreceptor neurons contain four distinct compartments, including an outer segment
(OS), inner segment (IS), nucleus, and synapse4,14,18,19. The OS is a highly modified
primary cilium and serves as the photon-sensing compartment of the photoreceptor4. The
OS contains hundreds of tightly-stacked double membranous discs which contain both
structural proteins required for proper OS structure, as well as most of the
phototransduction proteins required for photoreceptor light sensing, including rhodopsin14.

Although phototransduction takes place in the OS, all phototransduction proteins are
synthesized in the IS, which houses all of the organelles and machinery required for
protein biosynthesis 4. The IS can be broken down into two sub-compartments: the myoid
and the ellipsoid regions4. The myoid region contains the Golgi apparatus and
endoplasmic reticulum, while the ellipsoid region contains the machinery to support the
metabolic needs of the photoreceptor, including the mitochondria19. After synthesis in the
IS, OS proteins are subsequently trafficked through a narrow bridge known as the
connecting cilium (CC), which is hypothesized to have certain gate-keeping or otherwise
regulatory abilities18.

Transduction of electrical impulses from photoreceptors to bipolar cells occurs at the
photoreceptor synapse, located in the OPL. Rod synapses are known as rod spherules,
while cone synapses are referred to as cone pedicles. When Ca2+ levels are elevated in
photoreceptors in the dark, vesicles containing glutamate are released into the
presynaptic cleft. After light exposure and activation of phototransduction, Ca2+ is
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depleted and glutamate is no longer released19. In contrast to many other neurons which
utilize action potentials, photoreceptors are highly active and therefore utilize a
specialized type of chemical synapse known as a ribbon synapse20. The ribbon synapse
is a large plate-like structure which extends from the presynaptic terminal to the active
zone and is responsible for mediation of presynaptic communication through regulation
of vesicle exocytosis21-23. After presynaptic glutamate release, receptors on bipolar cell
postsynaptic terminals are stimulated or inhibited depending on whether the bipolar cell
is an ON -center or OFF-center bipolar cell.24 Although all photoreceptors utilize ribbon
synapses to communicate with downstream neurons, there are structural variations in the
ribbon synapse which differ between rods and cones20,25.

1.2.1.1 OS formation, maintenance, and disc morphogenesis
Photoreceptor neurons possess a highly modified primary cilium which is specialized to
be an efficient light sensor. Cilia are cellular organelles which are comprised of
microtubules26. Primary cilia, also known as sensory cilia, are non-motile cilia which
protrude from the apical surface of most postmitotic mammalian cells27. Primary cilia are
thought to be cellular ‘antennae’ which detect diverse stimuli from the extracellular
environment28. Ciliogenesis—the formation of such primary cilia—depends heavily on the
maturation and migration of the centrosome, a cellular organelle with well-documented
roles in cell division.29,30 The centrosome is comprised of two barrel-shaped structures
called the mother and daughter centrioles and each centriole is made up of nine triplet
microtubules31. In quiescent cells, the centrosome migrates to the plasma membrane
where the mother centriole docks and matures to form the basal body32,33. The basal body
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serves as both the anchor of the developing cilia, as well as the template for microtubule
nucleation of the core of the ciliary cytoskeleton, known as the axoneme28,33.

The initial steps of photoreceptor cilia formation follow the same stages of general
ciliogenesis4,34-38. First, a Golgi-derived vesicle (termed the primary ciliary vesicle) will
appear, attach to, and enclose the distal end of the mother centriole35. While traversing
the cell, the primary ciliary vesicle will fuse with additional post-Golgi vesicles to expand
in size, and invaginate to form the ciliary sheath4,38. This sheath will encapsulate the
growing ciliary bud26. Once reaching the plasma membrane, the ciliary vesicle fuses with
the plasma membrane of the IS, exposing the newly forming cilium to the extracellular,
apical side of the IS. Initiation of ciliogenesis has been shown to vary between
photoreceptors, with these first few stages of cilia formation generally occurring by
postnatal day 3 (P3) in murine retina37. However, short, protruding cilia are evident in
some murine photoreceptors beginning at P037,39. Next, the proximal portion of the cilium
will become the connecting cilium, or transition zone between the basal body and
axoneme, while the distal cilium will form the OS40. Finally, the axoneme will continue to
nucleate and extend from the basal body into the newly developed OS34,37.

1.2.1.1a OS disc morphogenesis
Hundreds of double membranous discs are stacked and discretely present in each
photoreceptor OS40. Mature rod OS disc membranes are completely enclosed within the
plasma membrane14. Alternatively, a large portion of cone discs are continuous with the
plasma membrane and the side of the disc opposite the cilia remains open to the

6

interphotoreceptor space41. The central portion of each mature disc, known as the
lamellae, is encompassed fully (in rods) or partially (in cones) by a disc rim14. While the
mechanism of photoreceptor OS disc formation has been debated for years, two
hypotheses have emerged to explain this process, termed the 1) evagination and 2)
vesicular fusion models4,14.

Figure 1.2. Evagination model of photoreceptor OS disc morphogenesis. The
photoreceptor neuron (right), depicted as a rod, has several distinct compartments and
structural features. The Steinberg et al two step model for OS disc morphogenesis shows
growing evaginations from the base of the OS and formation of the rim region (arrows) in
maturing discs. Mature discs, which are fully encapsulated within the plasma membrane,
are depicted by dotted lines. Adapted from Goldberg et al14.
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The evagination model describes the first step in disc morphogenesis as growth of
membrane protrusions, or evaginations, from the ciliary membrane away from the
axoneme (Fig. 1.2)42-48. These evaginations, which are contiguous with the plasma
membrane and have been shown to be fully open to the extracellular environment, will
later become the interdiscal space47-50. The space between evaginations will actually
become the discs. Several evaginations must form before older discs can undergo disc
rim formation, which is the second step of the evagination model of disc morphogenesis47.
In this step, the disc rim begins to form and encompass the disc membrane51. In rods, the
disc rim will enclose the entire disc membrane. In cones, although the majority of each
disc is circumscribed by a disc rim, the disc rim does not fully form. The evagination
closest to the base of the OS is very short in diameter. As each nascent disc forms in
rods, the older discs will grow in diameter until the evaginations fuse with the plasma
membrane. Mature rod discs are uniform in diameter and in thickness. The diameter of
cone discs varies, as the diameter will increase but then taper towards the distal portion
of the cone OS.

The vesicular fusion model for disc formation was first observed in the developing kitten
retina52. Irregular, vesicular structures were shown to accumulate within the ciliary plasma
membrane during ciliogenesis before any mature discs were formed. This model
postulates that these endocytic vesicles will eventually fuse to form mature, flattened
discs. Although the evagination model seems to be more heavily supported, other groups
have also shown evidence which upholds the hypothesis that OS morphogenesis occurs
due to endocytic membrane fusion1,39,53,54.
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1.2.1.1b OS renewal
The length of the photoreceptor OS must remain constant in order for each photoreceptor
neuron to have the proper number of disc membranes available to participate in efficient
phototransduction. In order for each photoreceptor to accommodate the nascent discs
growing at the base of the OS, discs residing in the apical portion of the photoreceptor
must be degraded. It is believed that shedding of the discs at the top of each OS occurs
in order to eliminate any damaged molecular components which have been compromised
due to continual exposure to photons of light4,34.

Behind the photoreceptor layer in the retina exist the RPE, which grow long processes
known as microvilli. These microvilli contact and sheath approximately 25% of each
photoreceptor tip14. Classical studies demonstrate that once injected radioactive amino
acids are incorporated into newly synthesized proteins in the IS of rod photoreceptors,
radioactively-labeled proteins are evident in newly forming discs at the base of the OS55.
Each day, these radioactively labeled amino acids travel up the OS toward the apical end
of the photoreceptor until they are eradicated. After removal from ROS, radioactive
molecules are evident within the cytoplasm of the RPE, demonstrating that RPE
participate in phagocytosis of shed discs56. Although the speed of disc renewal differs
between species, approximately 10% of the OS is renewed daily in mouse rods43,55,57.
The process of disc shedding, RPE phagocytosis, and OS renewal has also been shown
to be similar in cone photoreceptors42,58.

1.2.1.1c Proteins required for disc formation
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Mass spectrometry experiments have identified 11 proteins which are localized to OS
disc membranes59. Two of these proteins, peripherin-2 (PRPH2/RDS) and rhodopsin, are
required for OS disc formation. PRPH2 is confined to the disc rim region, while rhodopsin
is localized to the lamellae.

PRPH2 is a tetraspanin glycoprotein which has been shown to be crucial in photoreceptor
disc morphogenesis60-66. Long before the disease-causing mutation was linked to PRPH2,
the spontaneously-occurring rd2 or rds mouse was characterized67. In this mutant mouse
model, OS do not form and it was later found that the phenotype is linked to a mutation
in Prph2 which results in no translated PRPH2 protein60,62,68-72. PRPH2 is localized
specifically within the disc rim region, where it forms homo-tetramers with itself and
hetero-tetramers with its homologue rod outer segment membrane protein-1 (ROM-1)14,73.
In nascent discs at the base of the OS, PRPH2 is only found to localize to the hairpinclosure on the axonemal side of the immature disc49,51. Therefore, it is thought that
PRPH2 is initially concentrated in this location, and subsequently spreads throughout the
entire disc rim during rim formation. Notably, disc formation still proceeds in the absence
of ROM-1, though it is thought that ROM-1 plays an important modulatory role in disc
morphogenesis, as discs appear much larger in size when ROM-1 is not present74.

In addition to rhodopsin’s central role in the phototransduction cascade (discussed below),
proper expression of rhodopsin is also crucial for OS disc morphogenesis75,76. Strikingly,
rhodopsin comprises approximately 90% of protein in the OS77. Not only is the density of
rhodopsin kept extremely high at around 20,000 molecules/µm2, but has also been
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observed to form ordered nanodomains in the disc membrane78-80. Rods lacking
rhodopsin, or rods containing rhodopsin mutants which exhibit trafficking defects, do not
form OS75,76. Studies have also been done to determine whether OS development is
affected by the bioavailability of rhodopsin protein through characterization of a rhodopsin
over-expressing and under-expressing animal model81-83. In animals over-expressing
rhodopsin, where mouse retina also expresses bovine rhodopsin, OS are larger in
diameter81. In the under-expressing rhodopsin model (Rho+/-), where rhodopsin
expression is about half of wild-type (WT), OS are smaller in diameter and shorter83.
Alternatively, Interestingly, in these animals, rhodopsin density is kept constant in the OS
disc membranes though the diameter of discs and the length of the OS is altered84.

1.2.2 Photoreceptor Function
The main role of the photoreceptor is to initiate phototransduction in order to generate
signals of vision which can be transduced to downstream neurons and sent to the brain
for visual processing. These functions are detailed in rod photoreceptors below, although
phototransduction occurs similarly in cones, just with different protein isoforms. There are
five main steps which are required for initiation of phototransduction in rods, including 1)
activation of rhodopsin, 2) activation of the G-protein transducin, 3) activation of
phosphodiesterase 6 (PDE6), 4) hydrolysis of the secondary messenger of
phototransduction (cGMP), and 5) closure of cyclic nucleotide-gated (CNG) channels in
the OS plasma membrane (Fig. 1.3)85-87. Equally as important are the steps involved in
inactivation of the phototransduction cascade. While these steps of initiation and
termination of phototransduction are required for generating signals of vision, regulation
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of the photoreceptor membrane potential (photocurrent) is also crucial for proper
depolarization and hyperpolarization of the photoreceptor, a process which is required for
the cell to transduce these generated signals to downstream neurons. Many ion channels,
exchangers, and pumps in both the IS and OS are involved in this process of photocurrent
modulation88,89.

Figure 1.3. Initiation of the phototransduction cascade. Scheme representing the
activation of several key proteins in phototransduction within the rod OS disc membranes.
In the dark (top), proteins involved in the phototransduction cascade are inactive.
However, the high concentration of cGMP allows for opening of CNG channels, resulting
in the influx of Na+ and Ca2+. After light exposure (bottom), initiation of phototransduction
occurs in 5 steps. (1) activation of rhodopsin (R*), (2) activation of the G-protein
transducin, (3) activation of phosphodiesterase 6 (PDE6*), (4) hydrolysis of cGMP by
PDE6*, and (5) closure of CNG channels in the OS plasma membrane.
1.2.2.1 Initiation of phototransduction
Once light enters the eye and reaches the OS, rhodopsin becomes activated. As
mentioned previously, rhodopsin is comprised of an apoprotein called opsin and retinal,
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a chromophore13. In the dark, retinal exists as the isomer 11-cis-retinal, and in this state
rhodopsin is inactive. Photons reaching the OS are absorbed by 11-cis-retinal and induce
its isomerization to all-trans-retinal. This conformational change in rhodopsin results in its
activation; in this state it is often denoted as R* (Fig. 1.3, step 1)90-92.

Once rhodopsin is activated (R*), its partner G-protein, transducin is able to bind93.
Inactive transducin is a heterotrimeric protein comprised of one alpha, one beta, and one
gamma subunit (Gαtβγ)94. While inactive, Gαt is bound to GDP. Once rhodopsin is
activated, transducin transiently binds and Gat exchanges GDP for GTP. This GTP switch
results in activated Gat (Fig. 1.3, step 2)85-87. Activated Gat is then able to activate
phosphodiesterase 6 (PDE6) by binding to its regulatory gamma subunits (PDE6g). In
rods, PDE6 is comprised of its catalytic subunits, PDE6a and PDE6b, as well as its two
inhibitory gamma subunits. Once activated Gat binds both PDE6g subunits, PDE6 is fully
active (PDE6*) (Fig. 1.3, step 3) and begins to hydrolyze cGMP (Fig. 1.3, step 4)85-87.

In the dark, cGMP levels are kept fairly high and constant, maintaining a balance between
hydrolysis of cGMP and synthesis of cGMP by guanylate cyclase 1 and 2 (GC-1 and GC2) which are exclusively present in the disc membranes86. Under these conditions,
relatively abundant cGMP molecules bind to CNG channels in the OS plasma membrane
and keep them open. When open, these channels allow for influx of both Ca2+ and Na+
into the cell, which collectively support the dark current, rendering the photoreceptor
depolarized88. Once the phototransduction cascade becomes activated and PDE6*
begins hydrolyzing cGMP, cGMP is no longer available to bind to CNG channels, resulting
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in their subsequent closure and a decreased number of cations entering the cell85-87. This
overall decrease in circulating cations results in a more negative membrane potential and
the photoreceptor hyperpolarizes88. This hyperpolarization results in closure of Ca2+
channels at the synapse and clearance of glutamate from the post-synaptic cleft88.

1.2.2.2 The retinoid cycle
Once 11-cis-retinal isomerizes to all-trans-retinal in response to light, it is no longer active
and must be regenerated. Vertebrates utilize an enzymatic process known as the retinoid
cycle, commonly referred to as the visual cycle, in order to replenish visual pigment in
rods and cones90,95,96. While several pathways are hypothesized to supply enough 11cis-retinal to photoreceptors, the predominant pathway which has been characterized is
the classical visual cycle pathway97. Interestingly, it has been shown that much of this
pathway occurs in the RPE, as photoreceptors do not contain the proper machinery to do
so.

The classical visual cycle is largely mediated by retinol dehydrogenases (RDHs)98. As a
first step, all-trans-retinal is released by opsin and reduced to all-trans-retinol by NADPHdependent all-trans-RDH within the photoreceptor OS98,99. Next, all-trans-retinol is
translocated to the RPE, a process mediated by ATP-binding cassette transporter 4
(ABCA4)100. Once in the RPE, all-trans-retinol is esterified by an enzyme called
lecithin:retinol acyltransferase (LRAT)101. Retinoid isomerase (RPE65) then binds and
isomerizes all-trans-retinyl esters in order to synthesize new 11-cis-retinol102. Lastly, this
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11-cis-retinol is oxidized to 11-cis-retinal by other RDHs or generic dehydrogenases and
diffuses back to the photoreceptors, where it binds with opsin97,98.

1.2.2.3 Termination of phototransduction
Once visual transduction has taken place, a series of steps is required to terminate
phototransduction, preventing perpetual stimulation and allowing the photoreceptor to
respond to new stimuli. First, R* is hyperphosphorylated by rhodopsin kinase, or GRK186.
Although multiple phosphorylation sites are available on the C-terminus of rhodopsin,
studies have shown that it must be phosphorylated three times in order to bind an
inhibitory protein called arrestin-186,103,104. Next, Gat must be inactivated in order to
inactivate PDE6*86. The GTPase activating-protein (GAP) complex, comprised of
regulator of G-protein signaling 9 (RGS9), G protein b5 subunit (Gb5), and RGS9 anchor
protein (R9AP), is responsible for hydrolysis of the GTP attached to Gat and its
subsequent deactivation105-107. Although RGS9 is the only protein which has known GAP
activity, all proteins in this complex are crucial for inactivation of transducin.86,105-107

Lastly, cGMP levels must be restored to allow the photoreceptor to depolarize. As
mentioned above, GC-1 and GC-2 are responsible for synthesis of cGMP. Very little
cGMP is synthesized in the dark because the proteins which activate GC-1 and GC-2,
known as guanylate cyclase activating proteins (GCAPs), are bound to Ca2+ when
intracellular Ca2+ levels are high in the dark86. After light-induced hyperpolarization of the
photoreceptor, Ca2+ levels drop and GCAPs dissociate to bind and activate GC, resulting
in restoration of cGMP levels86. Once cGMP levels reach a certain threshold, CNG
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channels open to increase the amount of cations within the cell, causing cell
depolarization86. Once this occurs, the photoreceptor is ready to sense new stimuli.

1.2.2.4 Major regulators of the photocurrent
Although the CNG channels in the OS plasma membrane play a crucial role in mediating
the photoreceptor’s response to light, several other ion channels, exchangers, and pumps
also contribute to generation and shaping of the light response (Fig. 1.4)108. When the
photoreceptor is depolarized in the dark, the membrane potential of the cell is less
negative at -40 mV, and when it is
hyperpolarized

in

the

light,

it

becomes more negative at -75 mV88.
Many cations contribute to the dark
current, but it has been shown that
80% of the positive ions contributing
originates from the influx of Na+ ions,
15% from influx of Ca2+, and 5% from
influx of other ions, mainly Mg+
ions109.
Figure 1.4. Maintenance of the
photocurrent. Several ion channels,
pumps, and exchangers are involved
in maintenance of the photocurrent,
including the dark current (left) when
the photoreceptor is depolarized and
in the light when the photoreceptor is
hyperpolarized (right).
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Apart from CNG channels, the other ion transporter localized to the OS plasma
membrane is the NCKX exchanger, which works to rid the cell of excess Ca2+ ions88.
Interestingly, CNG channels actually form a complex with NCKX dimers in the OS110. For
every Ca2+ ion that is effluxed by the NCKX exchanger, one K+ ion is also effluxed, and
four Na+ ions are brought into the cell111. Due to the importance of the negative feedback
between Ca2+ and synthesis of cGMP by GC-1/GC-2, clearance of Ca2+ is very important
to maintain appropriate levels of cGMP.

In the IS plasma membrane, the main ion pump that helps to modulate the concentration
of intracellular Na+ is the Na+/K+-ATPase. This enzyme, which will be discussed in more
detail in later sections, has been shown to use approximately 50% of ATP in the retina112.
For every ATP that is hydrolyzed, the Na+/K+-ATPase removes three Na+ ions from the
cell and brings two K+ into the cell. In the dark, the Na+/K+-ATPase uses a high amount
of available ATP in order to help remove accumulating Na+ entering the OS88. In the light,
the Na+/K+-ATPase is still active, but utilizes less energy as the OS is more metabolically
active at that time88.

A total of four voltage-dependent currents have been shown to exist in the photoreceptor
IS or synapse, including the hyperpolarization-activated current (Ih), a dihydropyridinesensitive L-type calcium current (ICa), as well as two voltage-sensitive K+ channels, Ikx and
a TEA-sensitive delayed-rectifier type current [IK(V)]. Additionally, there are two Ca2+dependent currents, a Ca2+-activated Cl- current [ICl(Ca)] and a Ca2+-activated K+ current
[IK(Ca)]89,113,114. These currents are mediated by a number of ion channels and exchangers.
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Hyperpolarization-activated cyclic nucleotide-gated (HCN) ion channels in the IS
membrane of rods and cones, which are similar to the CNG channels in the OS, have
been shown to modulate the inward Ih current115. HCN channels open after light
stimulation in response to hyperpolarization of the photoreceptor, which counteracts the
loss of positive ions entering the cell in the OS, helping the cell to return to resting
membrane potential116. When these HCN channels are pharmacologically inactive,
photoreceptor light responses are heightened and last much longer, suggesting an
important role in recovery after light stimulation115,117. The Ikx current works in tandem with
the Ih current in order to filter rod light response, ridding the cell of accumulating K+ when
HCN channels are open following hyperpolarization, whereas the Ik(v) current helps to
remove K+ in the dark current88. Although the exact K+ channels responsible for mediating
these currents are not quite understood, several have been identified, including Kv1.2,
Kv2.1, Kv4.2, Kv7, Kv11.1, Kv8.2, and Ether-à-go-go (EAG)118-122.

In the synapse of photoreceptors are L-type voltage-gated calcium channels (VGCC)
which help to mediate the ICa current and synaptic transmission88,123. Although four
isoforms of VGCCs have been identified (Cav1.1-1.4), Cav1.4 has been shown to be the
isoform expressed in the photoreceptor synapse and is localized to the synaptic
ribbon88,123. Cav1.4 channels are open in the dark when the photoreceptor is depolarized,
allowing for influx of Ca2+ into the photoreceptor76. Influx of Ca2+ signals for
neurotransmitter-carrying synaptic vesicles to fuse with the plasma membrane and
release glutamate into the synaptic cleft76. In order to limit the amount of glutamate
released in the dark, there is an internal mechanism in place which involves intracellular
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Cl- and the ICl(Ca) current76. High intracellular Ca2+ signals for efflux of Cl- through channels
in the synapse; in rods these are channels which belong to the anoctamin or TEMEM16
family124,125. However, once intracellular Cl- decreases, Cav1.4 channels are inhibited to
reduce influx of Ca2+124,125. Once photoreceptors hyperpolarize in the light, these Cav1.4
channels will close, resulting in inhibition of glutamate release76.

1.2.3 Photoreceptor health & disease
All of the aforementioned structural and functional features of photoreceptors depend
heavily on the proper expression and function of a diverse set of visual and non-visual
proteins. Accordingly, mutations in hundreds of genes have been shown to cause
inherited blinding disorders with varying degrees of severity and etiologies. Additionally,
many other factors contribute to general retinal health, including age, diet, tobacco use,
and UV exposure126. A few blinding disorders which are particularly relevant to
photoreceptor health and function are retinitis pigmentosa (RP), Leber congenital
amaurosis (LCA), and macular degeneration.

The most common form of inherited blinding disorder affecting the retina is RP, which
affects 1 in every 3,000 to 5,000 people in the world127. Hundreds of mutations in over 50
different genes have been linked to RP (https://sph.uth.edu/retnet/home.htm)128, which
makes RP extremely heterogeneous in disease manifestation129. Many of these genes
code for proteins crucial to rod photoreceptor function and structure. The majority of RP
cases are autosomal recessive, while some are also X-linked recessive or autosomal
dominant. Patients diagnosed with non-syndromic RP present exclusively with visual
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defects, while mutations which cause syndromic RP also affect other sensory systems or
tissues130. RP is generally characterized by slow, progressive degeneration of rod
photoreceptors, with patients first experiencing night blindness. However, depending on
which specific RP-causing mutations are present, disease severity will vary. Patients with
mutations causing more severe forms of RP will experience complete loss of vision, while
others with mild RP may only lose a portion of their visual field129,130.

Although more rare, LCA is the most severe form of inherited retinal blindness and is the
main cause of childhood blindness, occurring in 1 in 30,000 to 81,000 people131. LCA is
generally characterized by severe vision loss or complete blindness from birth, with a
reduced or absent electroretinogram (ERG) by 6 months of age131,132. Two other clinical
features of LCA are amaurotic pupils and involuntary eye movement (sensory
nystagmus)131,132. A total of 14 genes have now been linked to LCA, most of which play
crucial roles in retinal function, including photoreceptor development and structure, the
retinoid cycle, transport across the connecting cilium, and phototransduction128,131.

Patients diagnosed with macular degeneration, commonly known as age-related macular
degeneration (AMD), experience central vision loss due to degeneration of the macula,
but often still retain peripheral vision133. The macula is a region in the center of the human
retina with a high concentration of cone photoreceptors; the very center of the macula
contains only cones and is called the fovea134. AMD can present as neovascular (“wet”)
or non-neovascular (“dry”), depending on the presence of abnormal retinal vascularization
which leaks blood or fluids into the macula133. In addition to degeneration of
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photoreceptors in the macula, AMD is also characterized by atrophy of RPE cells. A
hallmark of AMD is the presence of lipid deposits, known as drusen, on the basal and
apical side of RPE cells133,135. Many RPE- and photoreceptor-specific genes—including
BEST1, PROM1, PRPH2, ABCA4, and CTNNA1—have been linked to macular
degeneration, although other factors such as smoking and age are demonstrated risk
factors126,128.

Unfortunately, due to the number of disease-causing mutations which cause inherited
blinding disorders and the heterogeneity of disease, treatment is difficult and no
comprehensive cures exist. One of the most promising treatments of inherited diseases
of the retina is gene therapy, which describes the use of viral vectors to deliver normal
copies of the affected genes into diseased retina136,137. The hope is that delivery of
healthy versions of affected genes will result in expression of normal, functional proteins,
to slow degeneration and delay blindness137. Adeno-associated viruses (AAVs) are a
promising gene delivery vehicle, although there are limitations; gene therapy is not useful
in patients who have already experienced severe retinal degeneration137. Several other
techniques are being studied to help alleviate the burden of inherited blinding diseases,
including immunomodulatory therapy, stem cell therapy and regenerative medicine, as
well as artificial intelligence136.

1.3 Progressive rod-cone degeneration (PRCD)
Progressive rod-cone degeneration, or PRCD, is a photoreceptor-specific protein which
is localized to OS disc membranes59,138. Mutations in PRCD are linked to retinitis
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pigmentosa (RP) in dogs and humans. Although the specific role of PRCD has not yet
been ascertained, it seems to play an important role in high-fidelity disc morphogenesis139.
PRCD is a 54-amino acid protein (53 amino acids in mice), predicted to contain several
structural domains despite its structure being unsolved (Fig. 1.5). The sole cysteine
residue

of

PRCD

is

located on the N-terminus
at the second amino acid
and is post-translationally

Figure 1.5. Structural domains and post-translational
modifications of PRCD. PRCD is a 54 amino acid
protein (53 aa in mice), with several predicted structural
domains, RP-causing mutations, and phosphorylation
sites.
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transmembrane domain140. Immediately following these amino acids lies a polybasic
region, comprised of three arginine residues140. Interestingly, polybasic regions are
known to be important for strengthening a protein’s interaction with the plasma membrane
through electrostatic interactions between the positively charged amino acids and the
negatively charged phospholipid head groups142-144. Several amino acids after the
polybasic region, PRCD also contains a VxPx motif, which is a motif implicated in ciliary
targeting of proteins145. However, trafficking of PRCD to the OS has not been well
described and it is unclear whether the photoreceptor utilizes this VxPx motif to target
PRCD to the cilium, though association with rhodopsin does seem to be crucial for
trafficking141. Finally, although its significance is still not well understood, a portion of
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PRCD is phosphorylated141. Multiple phosphorylated residues have been identified in this
small protein, including serines 27, 38, and 44, as well as threonine 45146.

Interestingly, several mutations have been identified in this small protein which are linked
with RP (Fig. 1.5). The first and most prevalent mutation in PRCD is a cysteine to tyrosine
mutation at the second amino acid (PRCD-C2Y). Moreover, this PRCD-C2Y mutation
was first documented in and has been most studied in canines, as this mutation results
in the most common form of inherited blinding disease in dogs. However, this
homozygous mutation was also linked to a human patient with RP from Bangladesh147.
Another RP-linked PRCD mutation, found in one proband of Indian origin, is a
heterozygous arginine to cysteine mutation at the 17th amino acid (R17C), within the
polybasic region147. Interestingly, this heterozygous mutation has also been documented
in people of Indian or Pakistani origin who do not present with an RP phenotype147.
Another mutation which lies within the polybasic region is a homozygous R18X mutation,
which results in an early stop codon and has been documented in three siblings of Turkish
origin with RP148. A more prevalent homozygous R22X mutation has been reported in 18
different RP patients between nine families from a Muslim Arab village in northern
Israel149. Notably, a patient from Germany with RP was found to have inherited a different
heterozygous mutation from each of her parents150. In addition to inheriting a
heterozygous mutation for R18X from one parent, the patient was also found to carry a
mutation in the 25th amino acid, with a substitution of tyrosine for proline (P25T)150. Lastly,
a heterozygous valine to methionine (V30M) mutation is also linked to RP147.
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1.3.1 Progressive rod-cone degeneration in canines
In the 1970s and 80s, a recessive hereditary disorder termed progressive rod-cone
degeneration (PRCD), which later became the namesake of the affected protein, was first
extensively characterized in miniature poodles. PRCD-affected canines have retina which
develop normally with normal differentiation of photoreceptors, but later show signs of
improper disc stacking, disorganization and damage to the photoreceptor OS151-154. To
date, PRCD is the most common inherited blinding disease in canines, affecting over 30
dog breeds147,155,156.

1.3.1.1 Miniature poodles
The first study, which focused on visual response in the retina of miniature poodles
through analysis of electroretinography (ERG), showed that affected dogs presented with
reduced ERGs as early as 9.5 weeks154. Additionally, autoradiography using 3H-leucine
demonstrated that the process of OS renewal is slower in PRCD-affected animals,
although RPE appear normal151. This reduced rate of OS renewal was also later
confirmed using 3H-fucose152. In contrast to the first study analyzing ERGs where visual
defects were visible at 9.5 weeks, a second study from the same research group
demonstrated that defects in ERG response of tested canines were not evident until 28
weeks, a discrepancy which was attributed to increased genetic heterogeneity from
continued breeding of the colony of miniature poodles and potentially anesthesia151,154.

Although no morphological defects were apparent in PRCD-affected retina at 14.5 weeks
by light microscopy, electron microscopy revealed early PRCD disease onset, with
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vesicular profiles near the OS and within RPE microvilli, as well as rods with disorganized
OS and disoriented disc membranes151. At 30 weeks, abnormalities in morphology were
evident by light microscope, mainly affecting rods with ROS appearing both irregular and
indented. By 10 months of age, rod IS appeared shorter and OS were disorganized with
disoriented disc membranes, with areas of the outer nuclear layer (ONL) lacking rods
altogether. At 60 months, only cone photoreceptors remained and were localized strictly
to the posterior pole of the retina. Interestingly, a hallmark of PRCD-associated disease
in the miniature poodle is the presence of vesicular profiles near the OS membrane154.

1.3.1.2 English cocker spaniels
Recessively inherited retinal degenerative disorders which are similar to PRCD have
been identified in other dog breeds, such as the English cocker spaniel (ECS)153. A
hereditary blinding disease affecting ECS was found to generally mirror PRCD-associated
disease in miniature poodles, with very progressive retinal degeneration and loss of vision.
In contrast, the time of disease onset is much later and disease progression is much
slower, with elderly dogs still having some remanence of vision. Although disease
presented differently in ECS, through a series of cross-breeding experiments it was found
that this inherited blinding disease was in fact PRCD. In the majority of ECS with PRCDassociated disease, defects in visual response (measured by ERG) were not evident until
animals were over 12 months old, with rods affected much sooner than cones. In
comparison to miniature poodles, visual function also deteriorated much slower in
affected ECS. As in miniature poodles, OS became disorganized and disc membranes
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were disoriented. However, disease onset and progression occurred in a very different
manner, with spatial and temporal differences compared to the miniature poodle.

Vesicular profiles, which are one of the most prominent phenotypes in PRCD-affected
miniature poodles, are absent or sparsely distributed in affected ECS retina. Even in a
6.8 year-old ECS with PRCD, small areas of the retina contain rods and cones, although
there is evidence of OS disorganization and disc disorientation. Overall, researchers
found that PRCD-associated disease varies in location and time of disease onset and
progression, likely due to the genetic heterogeneity in each dog breed background.
Moreover, it was determined that although phenotypes of PRCD-associated disease
manifest differently between dog breeds, disease is a result of a single or multiple
mutations in a single genetic locus, as opposed to mutations at multiple genetic loci153.

1.3.1.3 Biochemical studies in PRCD affected canines
As disc orientation and stacking were highly affected in canines with PRCD, researchers
were interested in determining whether changes in opsin levels could lead to the defects
seen in rods, as opsin comprises the majority of protein in discs. Several other
photoreceptor-specific proteins were also analyzed. It was found that while opsin mRNA
levels became undetectable well into degeneration and started to decrease during early
degeneration, they were completely normal early in disease157. Although there was
differential expression of several photoreceptor-specific proteins, it seems that these
changes were not uniform and varied on a protein-by-protein basis158. While some
proteins were dramatically reduced in this time, including S-antigen, others were only
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slightly reduced, such as cone PDE6157,158. Interestingly, both b-transducin and
phosducin expression seemed to increase in the ROS early in disease, but varied later158.
Researchers also studied the role of the interphotoreceptor matrix in disease and
degeneration through staining for wheat germ agglutinin (WGA) and peanut agglutinin
(PNA), however all changes observed were concluded to be adaptive structural
responses following degeneration and subsequent cell death159.

1.3.2 Palmitoylation of PRCD
PRCD is one of 11 known proteins localized to photoreceptor OS discs59. Although no
transmembrane domain has been confirmed, PRCD does contain an N-terminal stretch
of hydrophobic amino acids thought to be crucial for membrane association140. PRCD
also contains a single cysteine residue, located at the second amino acid, which is
palmitoylated in retina and in cell culture140,141.

Palmitoylation is a unique post-translational lipid modification which involves the
reversible attachment of the 16-carbon fatty acid palmitate to cysteine residues on a
protein160. Lipidation of proteins generally increases their hydrophobicity and assists with
membrane association; however, palmitoylation also facilitates a variety of other
biological processes, including protein-protein interactions, maturation, signaling, activity,
and targeting to specific membrane microdomains144,161-163. Unlike many other posttranslational lipid modifications, palmitoylation is reversible, which grants it a dynamic role
in these processes. Protein palmitoylation is mediated by a class of enzymes known as
DHHC motif-containing palmitoyl acyltransferases (DHHC-PATs), of which 23 human
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isoforms exist with distinct tissue and subcellular distributions164-166. Depalmitoylation of
proteins is accomplished by enzymes known as palmitoyl-protein thioesterases
(PPTs)167,168.

Acyl resin-assisted capture (acyl-RAC), hydroxylamine treatment, and click chemistry
have been used to confirm palmitoylation of wild-type PRCD (PRCD-WT) both in vivo and
in cell culture140,141. PRCD is likely palmitoylated in the Golgi by zDHHC3, as cotransfection of zDHHC3 enhances PRCD-WT palmitoylation123. Importantly, the RPlinked PRCD-C2Y mutation discussed above results in loss of palmitoylation. Since
PRCD-C2Y protein levels are destabilized by more than 90% compared to PRCD-WT in
cell culture, palmitoylation appears to have a major role in PRCD protein level stability140.
In addition to destabilization of mutant PRCD-C2Y protein, loss of PRCD palmitoylation
also leads to its mislocalization140,141. Strikingly, PRCD-C2Y is not trafficked to the OS
like PRCD-WT, but instead accumulates within the IS, likely within subcellular
compartments140,141.

1.4 Na+, K+-ATPase
The Na+, K+-ATPase is a P-type ATPase which plays a major role in maintenance of ion
homeostasis in all cell types169. The pump hydrolyzes one molecule of ATP in order to
extrude Na+ from the cell and bring K+ into the cell in a 3 Na+:2 K+ ratio. The Na+, K+ATPase is an integral membrane protein and a heterodimer, made up of one alpha (a-)
and one beta (b-) subunit (Fig. 1.6). The a-subunit is the catalytic subunit of the pump,
containing the sites for ATP binding and hydrolysis and ion binding169. The a-subunit has
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ten transmembrane a-helices and is located mainly on intracellular side of the membrane.
On the other hand, the b-subunit is implicated in maturation and trafficking of the entire
enzyme to the plasma membrane170. The b-subunit has only one transmembrane a-helix,
a very short intracellular
domain, and a very large
extracellular domain with an
immunoglobulin-like
motif169. Studies have shown
that the a- and b- subunits
must associate with one
another at an 1:1 ratio within
the endoplasmic reticulum
(ER)

in

order

for

the

Figure 1.6. Structure of the Na+, K+-ATPase. Cartoon
representation of the a- and b- subunits of the Na+, K+-ATPase.

complex to exit and traffic to the Golgi171,172. If these two subunits do not associate, they
are retained in the ER and subsequently degraded171,172.

There are four known isoforms of the a-subunit, including ATP1A1, ATP1A2, ATP1A3,
and ATP1A4169. Furthermore, three isoforms of the b-subunit have been described,
including ATP1B1, ATP1B2, and ATP1B3 (Fig. 1.7)169. Although cell culture studies have
shown that any a-subunit can associate with any b-subunit, certain a-b preferences do
exist, and importantly, subunit isoforms are expressed in a cell-specific manner169,173. The
isoforms of the a-subunit of the Na+, K+-ATPase share a relatively high sequence
homology at ~87%, with the lowest between a1 and a4, with 78% similarity. However,
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the b-subunits are vastly different. The b2-subunit of the Na+, K+-ATPase only shares 58%
similarity with b1 and 61% with b3, while b1 and b3 share 68% homology174. Even though
the different b-subunit isoforms are quite different from one another, they do contain
several conserved domains, including three disulfide bonds and an immunoglobulin-like
domain within the large extracellular region of the protein174.

Figure 1.7. Structural domains and post-translational modifications of the bsubunit isoforms of the Na+, K+-ATPase.
One additional factor which contributes to the differences between the b-subunit isoforms
is the number of N-linked glycosylation sites, which have been implicated in protein
folding, maturation, and cell adhesion properties of the Na+, K+-ATPase (Fig. 1.6). The
b1-subunit contains three N-linked glycosylation sites, while b3 contains only two.
Glycosylation of b1 is crucial for proper interactions between b1 subunits of neighboring
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cells through localization to the lateral membrane175. The b2-subunit has eight different
glycosylation sites, which play a role in proper folding and maturation, as interactions with
calnexin (an ER lectin chaperone) are lost when ATP1B2 is not properly glycosylated176.

Although the a- and b- subunits are the only subunits required to form a functional Na+,K+ATPase heterodimer, many tissues also express a regulatory g-subunit of the Na+,K+ATPase. The g-subunit is a potent regulator of Na+,K+-ATPase activity, with seven known
isoforms (FXYD1-7) expressed in a tissue-specific manner177. Each g-subunit isoform of
the Na+,K+-ATPase has been shown to modulate channel activity differently, either
through upregulation or downregulation of pump activity178.

1.4.1 Alternative roles for the Na+, K+-ATPase
In addition to its role in ion transport, there is evidence that the Na+, K+-ATPase is also
involved in cellular adhesion and signal transduction. Cardiac glycosides such as ouabain
and digoxin have been extensively utilized in studying the Na+, K+-ATPase, as high levels
of ouabain inhibit Na+, K+-ATPase ion transport, but lower concentrations have been
shown to activate different signal transduction pathways179. Using ouabain, it has been
shown that the Na+, K+-ATPase is involved in mitogen-activated protein kinase (MAPK)
signaling, Ca2+ signaling, and phosphatidylinositol 3-kinase (PI3K)/Akt signaling179,180.
Apart from ion transport and signaling, the b1- and b2- subunits of the Na+, K+-ATPase
have been shown to serve as cell adhesion molecules in order to help mediate cell-cell
adhesion181,182.
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1.4.2 The retinal Na+, K+-ATPase
The predominant Na+, K+-ATPase subunits expressed in the mammalian retina are
ATP1A3 (a3) and ATP1B2 (b2); collectively, these subunits are commonly referred to as
the retinal Na+, K+-ATPase183-185. In relatively early investigations of the retinal Na+, K+ATPase, it was found that Na+, K+-ATPase expression is enriched within the IS of
photoreceptors as well as the inner and outer plexiform layers186. Soon after this
discovery, it was found that the predominant mRNAs of the Na+, K+-ATPase in retina were
those of a3 and b2, contributing 85% and 79% of total a-subunit and b-subunit mRNA,
respectively183. Immunoblotting confirmed these results and immunocytochemistry
demonstrated co-localization of a3 and b2 in the photoreceptor IS183,184. Photoreceptors
also express the b3 subunit late in their differentiation, although a3 and b2 are expressed
in undifferentiated photoreceptors at birth185. Despite the strong expression of a3 and b2
in the retina and exclusive expression of a3, b2, and b3 in photoreceptors, each of the
other subunit isoforms of the Na+, K+-ATPase have been identified in at least one retinal
cell type, except for a4185.

1.4.3 The b2-subunit of the Na+, K+-ATPase
Originally discovered as adhesion molecule on glia (AMOG), ATP1B2 was later
discovered to have sequence homology to the b-subunit of the Na+, K+-ATPase187,188. At
first, ATP1B2 was only found to be expressed in the brain, but has since been detected
in many other tissues189,190. Apart from its involvement in maturation and trafficking of the
ion pump to the plasma membrane, ATP1B2 has been shown to have other roles in the
cell. As its original name suggests, ATP1B2 was first discovered to be expressed by
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astroglia and was found to be important for mediating interactions between astroglia and
neurons187,191. Since then, it has also been implicated in neuronal migration, neurite
outgrowth, and cell-cell adhesion187,192.

To examine how ATP1B2 influences development and long-term integrity of neuronal
tissue, a mouse global knockout of Atp1b2 (AMOG-/-) was created193. Unfortunately,
neurological defects begin to affect AMOG-/- mice beginning at P15, resulting in death
between P17 and P18. Interestingly, retina from AMOG-/- mice present with 50% reduction
in thickness of the outer nuclear layer (ONL) at P17. Furthermore, both IS and OS appear
shorter in length compared to control mice (AMOG+/+). Although morphological defects
were observed in both retina and brain tissue, it was unclear whether the defects were
linked to the role of ATP1B2 in ion channel activity or the implications of ATP1B2 in
cellular recognition and adhesion193.

To better address whether neurological defects in AMOG-/- mice were a direct cause of
ion channel insufficiencies or non-pump functions of ATP1B2, a β1/β2 knock-in animal
was created194. This knock-in model expresses Atp1b1 cDNA in place of Atp1b2. Notably,
while substitution of ATP1B1 for ATP1B2 in the brain circumvented the neural pathologies
of AMOG-/- mice, retina of β1/β2 knock-in mice still degenerated. In β1/β2 knock-in retina,
Atp1b1 mRNA expression only appeared to be ~15% of the Atp1b2 mRNA expression of
wild-type animals. Although photoreceptor neurons still degenerated, degeneration took
much longer compared to retina from AMOG-/- mice. While 50% of photoreceptors
degenerated in AMOG-/- mice by P17, an equivalent loss of photoreceptors in β1/β2
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knock-in animals was not observed until 4 months of age194. Slowed photoreceptor
degeneration suggests that substitution of ATP1B2 with its homologue ATP1B1 does help
to restore normal Na+, K+-ATPase function in regard to ion channel activity. However,
much remains unknown regarding the specific need for ATP1B2 in the retina, especially
in terms of its role as a cell adhesion molecule.

1.4.4 The Na+, K+-ATPase is a membrane anchor for retinoschisin-1
An additional role for the retinal Na+, K+-ATPase is serving as a membrane anchor for
retinoschisin-1 (RS1)195,196. Mutations in RS1 are associated with X-linked retinoschisis
(XLRS), which results in early macular degeneration, and is characterized by splitting (or
“schisis”) of the inner layers of the retina197-201. RS1 is a secreted protein which is
expressed in both photoreceptor neurons and bipolar cells202. Once secreted, RS1 uses
the retinal Na+, K+-ATPase as a membrane anchor to help to maintain the synaptic
connections between photoreceptors and bipolar cells and preserve the structural
integrity of the retina195,196,202,203. Although it was originally thought that the entire retinal
Na+, K+-ATPase (ATP1A3 and ATP1B2) was required for membrane anchorage of RS1,
it was later found that RS1 binding only required expression of ATP1B2 and the a-subunit
was interchangeable180,204. In the absence of ATP1B2 from the retina, both ATP1A3 and
RS1 protein levels are severely reduced, suggesting that no Na+, K+-ATPase is present
in photoreceptors or bipolar cells when ATP1B2 is not expressed195.
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1.4.5 Disease associated with a3-subunit of the Na+, K+-ATPase
Although no disease-causing mutations in ATP1B2 have been reported, mutations in
ATP1A3 have been linked to various neurological disorders, including alternating
hemiplegia of childhood (AHC), rapid-onset dystonia parkinsonism (RDP), human optic
atrophy, and CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and
sensorineural hearing loss) syndrome205-208. Interestingly, while disease-causing
mutations for two of these disorders lead to atrophy of the optic nerve, no mutations in
ATP1A3 have been linked to retinal degeneration or visual defects despite the prevalence
of ATP1A3 in the retina205,208. Very recently, a family with cone-rod dystrophy (CORD)
presented with a novel mutation in ATP1A3 which results in residue 591 being mutated
from aspartate to valine209. Overexpression of mutant ATP1A3-D591V in HeLa cells
demonstrated defects in mitochondria resulting in decreased oxygen consumption rate
(OCR)209. Furthermore, in an animal model expressing mutant ATP1A3-D591V, scotopic
and photopic ERG responses were reduced209. While no mutations in ATP1B2 have yet
been identified, these disease-causing mutations in ATP1A3 highlight the crucial role of
the Na+, K+-ATPase in retinal health, and potential contributions of ATP1B2 remain
understudied.
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2.1 Abstract

Progressive rod-cone degeneration (PRCD) is a small protein localized to photoreceptor
outer segment (OS) disc membranes. Several mutations in PRCD are linked to retinitis
pigmentosa (RP) in canines and humans, and while recent studies have established that
PRCD is required for high fidelity disc morphogenesis, its precise role in this process
remains a mystery. To better understand the part which PRCD plays in disease
progression as well as its contribution to photoreceptor OS disc morphogenesis, we
generated a Prcd-KO animal model using CRISPR/Cas9. Loss of PRCD from the retina
results in reduced visual function accompanied by slow rod photoreceptor degeneration.
We observed a significant decrease in rhodopsin levels in Prcd-KO retina prior to
photoreceptor degeneration. Furthermore, ultrastructural analysis demonstrates that rod
photoreceptors lacking PRCD display disoriented and dysmorphic OS disc membranes.
Strikingly, atomic force microscopy reveals that many disc membranes in Prcd-KO rod
photoreceptor neurons are irregular, containing fewer rhodopsin molecules and
decreased rhodopsin packing density compared to wild-type discs. This study strongly
suggests an important role for PRCD in regulation of rhodopsin incorporation and
packaging density into disc membranes, a process which, when dysregulated, likely gives
rise to the visual defects observed in patients with PRCD-associated RP.
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2.2 Introduction

Rod and cone photoreceptor neurons contain a distinct membrane-rich structure at the
cilium known as the outer segment (OS). Each rod OS (ROS) is packed with over 1,000
tightly stacked, double membranous discs which house phototransduction proteins
required for normal photoreceptor function and structural stability1-6. In this study, we
focus on progressive rod-cone degeneration (PRCD), a small 54 amino acid (53 amino
acid in mice) protein which is specifically localized to OS disc membranes7. The most
common mutation in PRCD is a C2Y mutation, which is linked to retinitis pigmentosa (RP)
in humans and progressive retinal atrophy (PRA) in over 29 dog breeds8-10. RP and PRA
are both hereditary retinal disorders which result in degeneration of rods followed by
cones, leading eventually to complete blindness11-13. In canines and humans, PRCDassociated disease is characterized by progressive loss of vision and severe
disorganization of OS disc membranes 10,14-16.

Previous studies, including ours, have demonstrated that PRCD undergoes
palmitoylation, a post-translational lipid modification. Loss of palmitoylation in PRCD-C2Y
results in mislocalization of PRCD to the inner segment (IS), where it is rapidly
degraded17,18. Additionally, PRCD has been shown to interact with rhodopsin, a highly
abundant ROS protein which is responsible for initiation of phototransduction18-20. While
the significance of this interaction is not well understood, many animal models containing
mutations in rhodopsin have demonstrated the crucial role rhodopsin plays in ROS
maintenance and disc morphogenesis21-27. Within the ROS disc membranes, rhodopsin
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forms oligomers which are further organized into densely packed nanoscale domains2830

. Atomic force microscopy (AFM) imaging can achieve nanoscale resolution adequate

to visualize these nanodomains31. Strikingly, these AFM studies demonstrate that there
are biological mechanisms in place to ensure the density of rhodopsin in ROS disc
membranes is kept constant, suggesting that regulation of proper rhodopsin density is
crucial for photoreceptor disc formation and health32,33.

Although PRCD’s specific role within the photoreceptor remains elusive, recent studies in
a PRCD knockout mouse model have identified a requirement for PRCD in high fidelity
disc morphogenesis. In this model, it is observed that discs do not flatten or form properly
in the absence of PRCD. Consequently, membrane bulges containing rhodopsin appear
to separate into extracellular vesicles and accrue within the interphotoreceptor space34.
A second PRCD knockout mouse model has also shown accumulation of these vesicles
and observed a reduced rate of phagocytosis of OS discs by the retinal pigmented
epithelium (RPE)35. Along with evidence of retinal degeneration in these models and
structural defects exacerbated by microglia recruitment to clear these vesicles, it is clear
that PRCD is required for proper OS maintenance and disc morphogenesis; however
further studies are needed to clarify the precise mechanistic role which PRCD plays in
these processes.

To further understand the interaction between PRCD and rhodopsin, as well as PRCD’s
role in photoreceptor OS disc morphogenesis and maintenance, we utilized our Prcd-KO
mouse model. In this study, we demonstrate that Prcd-KO retina display dramatic
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disorganization of the photoreceptor OS. Most importantly, using AFM imaging, we
observe that loss of PRCD leads to decreased rhodopsin number and packaging density
in ROS disc membranes, likely associated with the observed morphological changes in
Prcd-KO retina.

2.3 Results

2.3.1 Generation of Prcd-KO mice using CRISPR/Cas9 genome editing
To better understand the importance of PRCD in the maintenance and stability of the
photoreceptor outer segment (OS), we generated a global Prcd-KO mouse model using
CRISPR/Cas9 genome editing. Among 48 founder mice, we found 12 contained INDEL
deletions in exon 1. For this study, we collected data from the 1738 founder, whose Prcd
gene contains a single nucleotide deletion in exon 1 at cytosine 61 (c61x), resulting in a
frameshift mutation (Fig. 2.1A and Supplementary Fig. S2.1). To rule out off-target effects,
additional founder lines were tested, including mice with a 14 bp deletion (1734) and 71
bp deletion in Prcd (1748) (Supplementary Fig. S2.1). All lines exhibited similar
phenotypes, were comparable in weight and development to wild-type (WT) littermates
and are fertile with no detectable health issues. Western blot analysis demonstrated that
lysate from Prcd-KO retina does not contain PRCD protein (Fig. 2.1B). Coimmunofluorescent labeling of retinal cross sections with antibodies against PRCD and
the OS marker anti-cyclic-nucleotide gated channel A (CNGA) revealed expected PRCD
OS localization in WT retina, whereas PRCD labeling was absent in Prcd-KO retinal
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sections (Fig. 2.1C). Altogether, these data validate the absence of PRCD protein in the
Prcd-KO animal model used in this study.

2.3.2 Loss of PRCD leads to progressive loss of visual function and slow
photoreceptor degeneration
To evaluate the visual response of rod and cone photoreceptor neurons, we assessed
scotopic (rod) and photopic (cone) responses in Prcd-KO and WT littermates by
electroretinography (ERG). A light-evoked ERG response is comprised of an “a-wave”
(photoreceptor)

and

a

“b-wave”

(inner

retinal

neurons),

which

result

from

hyperpolarization of photoreceptors and depolarization of downstream retinal neurons,
respectively36. At postnatal day (P) 30, Prcd-KO mice present with an approximate 30%
reduction in rod response compared to WT littermate controls in bright light conditions
(Fig. 2.2A). At low light intensities (0.00025 and 0.001 cd*s/m2), we were unable to identify
any discernable differences in scotopic rod response between WT and Prcd-KO animals.
However, at brighter flash intensities 0.158 (p = 0.009424), 0.995 (p = 0.001771), and 2.5
cd*s/m2 (p = 0.001363), rod a-waves were significantly reduced in Prcd-KO animals
compared to WT littermate controls (Fig. 2.2B). Furthermore, we observed a slow
decrease in visual response over time at various ages (P30, P60, P100, and P200); by
P200, Prcd-KO animals demonstrate an approximate 50% reduction in rod
photoresponse compared to WT littermate controls (Fig. 2.2C). In contrast, Prcd-KO
photopic ERGs demonstrated no noticeable changes compared to WT responses at any
tested ages or flash intensities (Fig. 2.2D). The evident impairment and gradual reduction
in rod visual function of Prcd-KO animals suggests a possible defect in the morphology
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or survival of photoreceptor cells. We utilized hematoxylin and eosin (H&E) staining of
WT and Prcd-KO retina at P30, P120, and P250 in order to analyze retinal morphology.
No significant defects in retinal lamination or morphology were observed in P30 Prcd-KO
mice (Fig. 2.2E). To determine if retinal degeneration was evident at P30, where we
observed significant loss of rod function in bright light conditions, we counted
photoreceptor nuclei at 10 different locations in the same H&E sections. No significant
reduction in photoreceptor nuclei was apparent in retina lacking PRCD until after P120.
At P250, we observed a significant reduction in photoreceptor nuclei, with approximately
23.8% fewer nuclei in Prcd-KO retina compared to WT (p = 0.001332; Fig. 2.2F). Based
on these data, the early rod ERG defects observed in bright light conditions were likely
not due to loss of rod photoreceptors.

2.3.3 Prcd-KO retina exhibit reduced levels of rhodopsin and increased structural
disorganization of rod OS as disease progresses
As Prcd-KO retina do not undergo degeneration until after P120, it is possible that the
observed defect in visual function is due to changes in major photoreceptor or discresident proteins, as PRCD is localized exclusively to the OS disc membrane. Therefore,
we analyzed retinal lysate from WT and Prcd-KO mice at P30 and P100 by western blot
and found no significant changes in any tested proteins (Supplementary Fig. S2.3).
However, due to the reported interaction between rhodopsin and PRCD, we measured
the concentration of rhodopsin in WT and Prcd-KO retina with spectrophotometric
analysis, a technique which has been widely used to measure and calculate picomolar
concentrations of rhodopsin in the retina37,38. At P30, total rhodopsin concentration was
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similar between Prcd-KO and WT retina (Fig. 2.3A). However, by P120, we observed a
20.4% decrease (p = 0.000072) in the amount of rhodopsin per Prcd-KO retina compared
to age-matched WT controls (Fig. 2.3B). Despite the observed decrease in rhodopsin
protein at P120, rhodopsin mRNA levels were comparable between WT and Prcd-KO
animals at P30 and P120 (Supplementary Fig. S2.4). Furthermore, no mislocalization of
rhodopsin is evident at P120 in Prcd-KO retinal sections when analyzed by
immunofluorescent staining (Supplementary Fig. S2.5).

To gain further insight into the observed reduction in rod photoreceptor function at P30,
we investigated photoreceptor ultrastructure at various ages (P30, P60, and P120) using
transmission electron microscopy (TEM). At the earliest tested age (P30), many Prcd-KO
rod photoreceptors contained discs that were disoriented and vertically aligned, although
rod OS had an overall normal shape (Fig. 2.3D; arrowhead). Ultrastructural analysis of
Prcd-KO rods at P60 showed the OS layer to be disorganized compared to WT. Outer
segments had irregular diameters, included frequent examples of overgrown and
misoriented disc membranes, and occasionally shed OS fragments and whorls of
membrane packets into the OS layer. Closer inspection revealed a distinct population of
Prcd-KO rods containing small packets of overgrown discs (10-40 discs), which were
aligned abnormally, having grown along the long axis of the photoreceptors (Fig. 2.3E
and Supplementary Fig. S2.6B-E). Although these defects were observed in Prcd-KO
rods, there were still many rods which were comparable to WT, with no apparent
differences in gross OS ultrastructure and contained nicely stacked, correctly sized, and
properly aligned disc membranes (Supplementary Fig. S2.6A, B, and F). Additionally, our
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evaluation of Prcd-KO retina ultrastructure found no apparent difference in the connecting
cilium, inner segment (IS), mitochondria, or adjacent RPE layer compared to WT
littermates. With increased age, Prcd-KO mice showed an increased frequency of
defective photoreceptor cells with incorrectly stacked discs, further disorganization of
ROS, and more space between discs at P120 compared to age-matched WT (Fig. 2.3C
and F).

2.3.4 Disc membranes in Prcd-KO rod photoreceptors contain reduced packaging
density and number of rhodopsin molecules
To investigate the interplay between rhodopsin and the observed defects in the Prcd-KO
ROS ultrastructure, we evaluated ROS disc membranes isolated from Prcd-KO mice and
age matched WT controls by atomic force microscopy (AFM). Previous studies have
successfully used AFM to visualize rhodopsin nanodomains in the disc membranes39.
Rhodopsin nanodomains are formed by oligomers of rhodopsin of various size and are
not an artifact of phase separation of lipids or those related to the AFM procedure28,30,40.
To further our confidence in this detection method, ROS disc membranes from WT mice
at P30 and P120 exhibited properties similar to those reported previously30,32 (Fig. 2.4AC). In these discs, rhodopsin was arranged into nanodomains and the nanodomains were
largely densely packed within the disc (Fig. 2.4A-C). Prcd-KO mice at P30 and P120
exhibited some ROS disc membranes which resembled those from WT mice with
rhodopsin nanodomains densely packed within the membrane (Fig. 2.4D and G);
however, they also exhibited ROS disc membranes that were irregular. Irregular ROS
disc membranes from Prcd-KO discs had fewer rhodopsin nanodomains with larger areas
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devoid of rhodopsin nanodomains (Fig. 2.4E, F, H, and I; asterisks). Irregular ROS disc
membranes were also observed for WT mice; however, they were only sporadically
observed, representing 6% or less of the ROS disc membranes analyzed. The proportion
of regular and irregular ROS disc membranes were quantified for P30 and P120 Prcd-KO
mice. In P30 KO mice, about one-third of the ROS disc membranes were irregular, and
this increased for P120 mice, where about half of the ROS disc membranes were irregular
(Fig. 2.5A, Table 2.2). Thus, the proportion of irregular ROS disc membranes increased
with age for Prcd-KO mice. Since ROS discs from photoreceptor cells are heterogeneous,
quantitative analysis is required32. The number of rhodopsin contained within a ROS disc
membrane was estimated from the size of nanodomains and the density of rhodopsin
was computed presuming single rhodopsin molecules homogenously distribute
throughout the area of the lamellar region of the discs39. The number and density of
rhodopsin nanodomains and molecules of rhodopsin in the irregular ROS disc
membranes of both P30 and P120 mice were lower compared to that of regular ROS disc
membranes (Fig 2.5B-E). The regular ROS disc membranes of both P30 and P120 PrcdKO mice contained a similar number and density of rhodopsin as that of WT ROS disc
membranes (Table 2.3). Altogether, these data demonstrate that Prcd-KO mice have an
impaired ability to form proper ROS disc membranes with sufficient rhodopsin number
and packaging density.

2.4 Discussion
In the current study, we sought to further understand the role of PRCD, a small discresident protein, in photoreceptor disc morphogenesis. Mutations in PRCD are associated
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with dramatic misalignment of disc membranes and disorganization of the OS, followed
by slow retinal degeneration. The most common PRCD mutation (C2Y) has been
extensively characterized in several dog breeds16. Recent studies in additional mouse
models have shown that high fidelity disc morphogenesis is compromised when PRCD is
not present34,35. However, the precise role PRCD plays in this process remains unclear.
In this study, we demonstrate that loss of PRCD disrupts rhodopsin packaging into ROS
disc membranes, leading to defects in visual function and compromised OS structure,
phenotypes consistent with clinical findings in humans and dogs with a PRCD-C2Y
mutation10.

Previous

studies

in

canines

demonstrate

that

PRCD-associated

disease

is

heterogeneous, with spatial and temporal differences in disease onset and progression
between dog breeds14,15,41 In these models, it is reported that changes in ERG response
correspond to the presence of morphological defects in affected animals16. In our PrcdKO mouse model, retina appear to develop normally, exhibiting proper lamination. Our
ERG studies demonstrate that loss of PRCD impairs mass rod photoreceptor response
in bright light conditions as early as P30. At P30, ultrastructural analysis reveals Prcd-KO
rod photoreceptors with defects in OS morphology, including focal misalignment of discs
and imperfect disc stacking. As mice age, ERG response continues to decline and more
pronounced morphological defects are observed. Importantly, all tested disc-resident and
phototransduction proteins appear normal in Prcd-KO retina at P30, suggesting the
observed reduction in Prcd-KO rod response at this age is due to morphological defects
rather than loss of crucial phototransduction proteins34.
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Similar to two recently published mouse models lacking PRCD, photoreceptor
degeneration in our Prcd-KO mice occurs well after disease onset, as we only see
significant degeneration after P120. However, it seems that disease onset occurs earlier
in our mouse model compared to others. In one model, Spencer et al report that single
cell recording of rods shows no differences in visual response compared to WT at P40P45. Additionally, Prcd-/- rods appear relatively normal compared to WT at 2 months, with
only a few deformed ROS34. In another model, Allon et al report that mass rod response
was not reduced until after 20 weeks of age and do not mention disorganized disc
membranes until 30 weeks35. We believe these discrepancies can be explained by mouse
strain differences and genetic heterogeneity, as our Prcd-KO model is in a 129/SV-E
background and the other two are in a C57BL/6J background. If the characterized
correlation between ERG response and morphology in canines with a PRCD-C2Y
mutation holds true in Prcd-KO animals, it explains why we see reductions in ERG
response at P30 when we also observe morphological defects. Additionally, it may explain
why ERG response is not affected in these other knockout models, when ROS appear
normal.

These models also show that retina lacking PRCD develop an abundance of extracellular
vesicles (EV) containing rhodopsin, which phagocytic microglia cannot manage to clear
properly34,35. Spencer et al demonstrates that discs lacking PRCD do not form properly
and that prior to flattening, membrane bulges containing rhodopsin separate into EV in
the interphotoreceptor space34. We were able to identify several examples of EV in our
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model, but they often appear in the same areas as fixation artifacts and were also
observed in WT retina. These newly formed EV are likely labile structures which require
cardiac perfusion to retain their ultrastructure. It is important to note that the presence of
vesicular profiles is also a hallmark of PRCD-associated disease in miniature poodles14.
However, these vesicular profiles were reported to be missing or sparsely distributed in
retina of English cocker spaniels with PRCD-C2Y mutations16. Therefore, while the
traditional TEM fixation protocols used in this study may not have captured these vesicles
properly, it is also possible that formation of these vesicles is just another phenotypic
variation that can be attributed to genetic differences in mouse strain, as demonstrated in
canine models. We plan to investigate this possibility in our future studies. In general, the
variable phenotypes observed in canines and mice with PRCD-associated disease
underscores the importance of continued study of this protein in multiple model systems.

In contrast to other published studies, we furthered our analysis of Prcd-KO disc
membranes using AFM. PRCD is identified as one of 11 proteins exclusively present in
the disc membrane and has been shown to interact with rhodopsin7,18. As mentioned,
rhodopsin is organized into nanoscale domains and AFM has been extensively used to
visualize these nanodomains in various studies28,30,32,42,43. Rhodopsin protein is reduced
by half in Rho+/- retina and AFM analysis of Rho+/- discs demonstrates that although
disc size decreases in response to availability of rhodopsin, at 6 weeks of age, Rho+/disc membranes contain a density of rhodopsin comparable to WT22,32. With an average
density of about 20,000 µm-2 in murine discs, rhodopsin is likely maintained at this density
in order for rods to retain high sensitivity to light23,30,33,39,44,45. In fact, high rhodopsin
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packaging density appears very important for proper visual function, as mice housed in
constant dark display increased rhodopsin packing density within ROS disc membranes
and show improved visual function compared to mice housed in cyclic light conditions33.
In contrast to tight regulation of rhodopsin packaging density, our Prcd-KO mice
demonstrate a population (~33%) of “irregular” discs at P30 which contain both fewer
molecules of rhodopsin and decreased density of rhodopsin in comparison to WT “regular”
discs. By P120, the relative proportion of these irregular discs increases to ~50%,
corresponding with worsening retinal defects as assessed by ERG and TEM. Thus, if
there do exist mechanisms to maintain consistent rhodopsin packaging density in ROS
disc membranes, our data suggest that PRCD may be involved in regulation of this
process.

Although rhodopsin levels and availability appear relatively normal in Prcd-KO retina at
P30, there is an apparent inability for rod photoreceptor neurons lacking PRCD to
maintain the proper density of rhodopsin within ROS disc membranes. Furthermore, the
presence of these irregular discs strongly suggests a possible explanation for the
observed reduction in Prcd-KO rod ERG response and ROS ultrastructural defects at P30
and subsequent ages. By P120, we detect an approximate 20.4% reduction in total
rhodopsin protein. We speculate that this decrease is related to the disrupted
incorporation of rhodopsin into these aforementioned irregular discs.

In all PRCD knockout models to date, cones appear unaffected until rods degenerate. As
cones rely on opsins other than rhodopsin for phototransduction, the specific role for
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PRCD in rod photoreceptors through packaging of rhodopsin into disc membranes is
compelling. Considering PRCD’s small size, one hypothesis is that PRCD works by
anchoring nascent discs in place to ensure that the proper density of rhodopsin is packed
into each disc before flattening and enclosure. Investigation of this possibility, as well as
determining why Prcd-KO rods are still able to form a population of phenotypically normal
discs, are topics of future study.
Altogether, our data provide further insight into PRCD’s involvement in proper rhodopsin
packaging density in ROS disc membranes, a process which is crucial for OS
maintenance and disc morphogenesis.
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2.5 Methods

2.5.1 Generation of Prcd knockout model
Prcd-KO mice were generated using CRISPR/Cas9 genome editing at the transgenic
core facility at West Virginia University. Small guide RNA (sgRNA) were designed as
described in earlier studies46,47. Two sgRNA target sequences were created for exon 1 of
Prcd,

both

upstream

(CCGTAGATTTACCAACCGAGTGG)

and

downstream

(CCACTCGGTTGGTAAATCTACGG) of the 5’-NGG “PAM” (protospacer adjacent motif).
These sequences were annealed and ligated into a pX330 vector (pSpCas9). Using PCR
amplification, a T7 promoter (TTAATACGACTCACTATAGGG) was added to the sgRNA
template and purified using an RNA purification kit from Ambion. After confirming the
specificity and efficacy of the sgRNA/Cas9 cutting by in-vitro assays, both sgRNA
(17ng/µl) and Cas9 (34 ng/µl) mRNA (Invitrogen) were injected into the pronuclei of FVB
blastocysts. The correctly targeted founder mice were identified by sequencing and
backcrossed with 129/SV-E mice (Charles River Laboratories) to eliminate the rd1 allele,
which naturally occurs in FVB mice. Furthermore, Prcd-KO mice were confirmed to lack
the rd8 mutation and were extensively backcrossed for more than 6 generations with
129/SV-E mice to rule out “off-target” effects sometimes associated with CRISPR/Cas9
gene editing. Genotyping was performed by PCR amplification followed by sequencing.
All experimental procedures involving animals in this study were approved and conducted
in strict accordance with relevant guidelines and regulations by the Institutional Animal
Care and Use Committee at West Virginia University.
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2.5.2 Electroretinography
Prior to measuring light dependent electrical response, mice were dark-adapted overnight
before testing and ERGs were performed under dim red light. Animals were anesthetized
with isoflurane (5% in 2.5% oxygen) and eyes were dilated (1:1 Phenylephrine :
Tropicamide) for 10 minutes and placed on a stage heated to 37ºC with a nose cone
supplying isoflurane (1.5% in 2.5% oxygen) for testing. After lubrication with GenTeal gel
(0.3% Hypromellose), silver electrodes were placed above the cornea to measure ERG
response. A reference electrode was placed between the ears on top of the animal’s head.
ERG recordings were conducted using the UTAS Visual Diagnostic System with BigShot
Ganzfeld, UBA-4200 amplifier and interface, and EMWIN software (version 9.0.0, LKC
Technologies, Gaithersburg, MD, USA). Scotopic (rod) ERGs were performed in the dark
with flashes of white light at increasing intensities. Photopic (cone) responses were
performed with flashes of increasing intensities of white light with a 30 cd/m2 white
background light for 10 minutes to saturate rods.

2.5.3 Immunoblotting
To evaluate protein expression by immunoblot, two retinas were homogenized by
sonication (Microson Ultrasonic cell disruptor, 3 pulses 5 s at power setting 10) in 200 µl
of urea sample buffer (USB) containing 6M, 4% SD0S, and 125 mM Tris-HCl, pH 6.8
in1.5-ml microcentrifuge tube on ice. Protein concentration was determined using a
NanoDrop spectrophotometer (ND-1000, Thermo Fisher Scientific).

Samples were

normalized to 5 mg/ml with additional USB and 5% 2-mercaptoethanol and bromophenol
blue were added prior to SDS-PAGE. Equal concentration of each sample was loaded
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and separated by SDS-PAGE in a 4-15% tris-glycine precast gel (4–20% Mini-PROTEAN
TGX, Bio-Rad, Hercules, CA, USA) and subsequently transferred to an Immobilon-FL
PVDF membrane (Immobilon-FL, Millipore, Burlington, MA, USA). After blocking
membranes with blocking buffer (Odyssey Blocking Buffer; LI-COR Biosciences, Lincoln,
NE, USA) for 1 hour at room temperature (RT) and incubated with primary antibodies for
2 hours at RT or overnight at 4°C on a bidirectional rotator. After primary antibody
incubation (see Table 2.1), immunoblots were washed three times in 1X PBST (1X
PBS/0.1% Tween-20) for 5 minutes each at RT and incubated with secondary antibody,
goat anti-rabbit Alexa Fluor 680, goat anti-mouse DyLight 800 or donkey anti-sheep Alexa
Fluor 680 (Thermo Fisher Scientific) for 30 minutes at RT. After washing three additional
times in 1X PBST, membranes were scanned using an Odyssey Infrared Imaging System
and protein density was measured according to manufacturer’s instruction (LI-COR
Biosciences, Lincoln, NE, USA).

2.5.4 Immunohistochemistry
Whole eyes from P30, P120, and P250 were enucleated, immersed, and fixed in
Excalibur’s Z-fix. Embedding, sectioning, and hematoxylin and eosin (H&E) staining was
carried out on WT and Prcd-KO eyes by Excalibur Pathology, Inc. (Norman, OK, USA).
Images were collected using a Nikon C2 confocal microscope. Five points were chosen
to count the number of photoreceptor nuclei in the outer nuclear layer (every 350 µm)
above and below the optic nerve. Counts were completed for three independent eyes
(n=3) and averaged to determine the amount of photoreceptor degeneration at each age.
Images were processed using ImageJ software along with the Bio-Formats plugin48,49.
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2.5.5 Immunofluorescent staining
After enucleation, mouse eyes were prepared as described previously17. Using a Leica
CM1850 Cyrostat, 16 µM cross-sections were cut and placed on Superfrost plus slides
(Fisher Scientific). Slides were washed with 1X PBS to hydrate tissue and to remove OCT.
To prevent non-specific antibody labeling, slides were blocked for 1 hour. After blocking,
primary antibodies were added at a 1:1000 dilution and incubated overnight at 4 °C (see
Table 2.1). After primary antibody incubation, sections were washed in 1X PBST (1X
PBS/0.1% Triton X-100) three times and incubated with the nuclear stain DAPI (1:5,000;
Molecular Probes) and secondary antibody (Thermo Fisher Scientific goat anti-mouse
Alexa Fluor-488 or goat anti-rabbit Alexa Fluor-568) at a 1:1,000 dilution for 1 hour at RT.
Slides were mounted with Prolong Gold antifade reagent (Thermo Fisher Scientific) and
coverslipped (1 mm). Slides were imaged using a Nikon C2 confocal microscope. Images
were processed using ImageJ software along with the Bio-Formats plugin48,49.

2.5.6 Transmission electron microscopy
Enucleated eyes were placed in freshly prepared buffer containing 2% paraformaldehyde,
2.5% glutaraldehyde, and 0.1M cacodylate buffer, pH 7.5. After 30 minutes of fixation,
cornea and lens were removed, and eyecups were fixed for an additional 48 hours at RT
with constant rotation on a nutator. Dissection, embedding, and transmission electron
microscopy were performed as described previously50.
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2.5.7 Rod outer segment and disc membrane isolation
Retina from 15 age-matched WT (129/SV-E) and Prcd-KO mice were collected. Retinal
tissues were suspended in 300 µl of 8% (vol/vol) Optiprep (Sigma-Aldrich, St. Louis, MO,
USA) in Ringer’s buffer (10 mM HEPES, 130 mM NaCl, 3.6 mM KCl, 2.4 mM MgCl2, 1.2
mM CaCl2, and 0.02 mM EDTA) and vortexed for 1 minute. Next, samples were
centrifuged at 238 x g for 1 min at 4ºC and the supernatant was collected into a clean
tube. This was repeated four additional times and the subsequent supernatant was
pooled and placed on top of a 10-30% Optiprep in Ringer’s buffer gradient. The gradient
containing the sample was then centrifuged at 26,500 x g for 50 minutes at 4ºC with no
brakes (Beckman Coulter Optima LE-80K; SW-41Ti). A dense band approximately twothirds from the top of the gradient was collected and diluted fourfold in Ringer’s buffer.
After a 3 minute centrifugation at 627 x g at 4ºC, the supernatant was next transferred to
a high-speed centrifuge tube and centrifuged at 26,500 x g for 30 minutes at 4ºC
(Beckman Coulter Optima TLX; rotor-TLA55). The resulting pellet was then resuspended
in 2 mM Tris-HCl and used for AFM studies.

2.5.8 Atomic force microscopy
All experimental procedures were conducted under dim red light conditions to avoid
photobleaching. ROS disc membranes were diluted in Ringer's buffer (10 mM HEPES,
130 mM NaCl, 3.6 mM KCl, 2.4 mM MgCl2, 1.2 mM CaCl2, and 0.02 mM EDTA, pH 7.4),
immobilized on freshly cleaved mica and imaged by AFM in imaging buffer (20 mM Tris,
150 mM KCl, 25 mM MgCl2, pH 7.8), as described previously32. Contact mode AFM
imaging was performed using Bruker Multimode II atomic force microscope equipped with

76

an E scanner (13 µm scan size) and silicon nitride cantilevers with a nominal spring
constant of 0.06 N/m (DNP-S, Bruker, Santa Barbara, CA). Deflection images were
analyzed using SPIP (version 6.5, Image Metrology A/S, Hørsholm, Denmark) to
determine the number and density of rhodopsin, as described previously32,39. Graphs and
statistical analyses were done using Prism 7 (GraphPad Software, San Diego, CA).

2.5.9 Rhodopsin measurement
The amount of rhodopsin (picomoles per retina) was assessed using a modified
protocol37,38. The concentration of rhodopsin was determined by measuring the difference
in absorbance using a spectrophotometer before and after bleaching of the sample with
a known light intensity. Individual retina were dissected in the dark under dim red light
and placed in 200 µl of water containing 10% n-octyl-β-d-glucopyranoside and 50 µl of
200 mM hydroxylamine, pH 7.5. After sonication, the sample was centrifuged at 14,000
rpm in a tabletop centrifuge for 30 seconds and 150 µl of sample was measured by
spectrophotometer before and after light exposure. Absorbance and a molar extinction
coefficient of 40,500 were used to calculate the concentration of rhodopsin per retina37,38.

2.5.10 Statistical analysis
Data are expressed as means ± S.E.M., unless otherwise indicated. The differences
between littermate or age matched control (WT) and experimental animals (Prcd-KO)
were

analyzed

with

a

two-tailed

https://www.socscistatistics.com/).
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student
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test

(online
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2.7 Figures and Figure Legends

Figure 2.1. (A) Scheme demonstrating the generation of the Prcd-KO animal model using
CRISPR/Cas9 technology. In this study, we used the 1738 founder line, which has a
single base pair deletion in exon 1 of Prcd. UTR = untranslated region, CDS = coding
sequence. (B) Immunoblot analysis shows loss of PRCD protein from Prcd-KO retinal
lysate at postnatal (P) 30 and P100, whereas wild-type (WT) retinal lysates demonstrate
PRCD immunoreactivity (n=4). Please note that immunoblot data is cropped; full-length,
raw data is available in Supplementary Fig. S2.2. (C) Immunofluorescent staining of P30
retinal cross-sections from WT and Prcd-KO mice, probing with antibodies against PRCD
(red) and the OS marker cGMP-gated cation channel alpha-1 and alpha-3 (CNGA 1/3;
green) to demonstrate proper localization of PRCD to the OS in WT retina and loss of
PRCD from Prcd-KO retina (n=3). Scale bar = 20 µm. All experiments were conducted
with littermate controls.
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Figure 2.2. Reduced rod photoreceptor function and slow retinal degeneration in
animals lacking Prcd. (A) Representative waveform from scotopic ERGs of WT (black)
and Prcd-KO (grey) animals at P30 (0.995 cd*s/m2). (B) Significant loss of rod
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photoreceptor function at higher light intensities (0.158, 0.995, and 2.5 cd*s/m2)
compared with low light conditions (0.00025 and 0.001 cd*s/m2) (n=4, data from B and C
stats are unpaired two-tailed t-test; higher light intensities were statistically significant, *p
< 0.01; Low light intensities were not significant). (C) Maximum a-wave amplitude of PrcdKO animals at different ages compared to WT controls from P30 to P200. (D)
Representative waveform from photopic (cone) ERGs of Prcd-KO and WT animals at
P200 (7.9 cd*s/m2) (n=4). (E) Prcd-KO and WT littermate control cross-sections stained
with hematoxylin and eosin (H&E), imaged by light microscopy, at P30, P120, and P250.
Scale bar = 20 µm. (F) Quantification of number of photoreceptor nuclei in the outer
nuclear layer (ONL) from both Prcd-KO (grey) and WT littermate controls (black), every
350 µm from the optic nerve, at P30, P120, and P250. Data are represented as mean
(n=3, unpaired two-tailed t-test; *p < 0.01).

85

Figure 2.3. Reduced rhodopsin concentration and aberrant ultrastructure of
photoreceptor OS during disease progression in Prcd-KO mice. (A) Quantification
of total rhodopsin (pmol rhodopsin/retina) in WT and Prcd-KO retina at P30. (B)
Quantification of total rhodopsin (pmol rhodopsin/retina) in WT and Prcd-KO retina at
P120. Data is reported as the mean (unpaired, two-tailed t-test; ***p = .000072). (C) TEM
image of the photoreceptor OS and well organized disc membranes at P120 (WT). (D-F)
TEM ultrastructure of photoreceptor OS at various ages in Prcd-KO retina show the
progressive disruption of OS structure from (D) P30, (E) P60, and (F) P120. Arrowheads
indicate the defective and disorganized disc membranes. Scale bar = 500 nm.

86

Figure 2.4. Representative AFM images of ROS disc membranes isolated from WT
and Prcd-KO retina. Representative AFM images of ROS disc membranes isolated from
(A-C) WT retina at P120, (D-F) Prcd-KO retina at P30, and (G-I) Prcd-KO retina at P120.
Asterisks indicate large areas without rhodopsin nanodomains. Scale bar = 500 nm.
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Figure 2.5. Quantification of ROS disc membrane properties of WT and Prcd-KO
mice. (A) Relative population of regular (black) and irregular discs (grey). (B) Number of
rhodopsin nanodomains packed into a ROS disc membrane. (C) Density of rhodopsin
nanodomains within a ROS disc membrane. (D) Number of rhodopsin molecules packed
into a ROS disc membrane. (E) Density of rhodopsin molecules within a ROS disc
membrane. The number of ROS disc membranes analyzed are as follows: P30 WT, n=48;
P30 KO regular, n=61; P30 KO irregular, n=27; P120 WT, n=47; P120 KO regular, n=53;
P120 KO irregular, n=48. Mean values are reported with the standard deviation (unpaired,
two-tailed t-test; *p £ 0.05, **p £ 0.01, ***p £ .00001).
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2.8 Tables

Table 2.1. List of primary antibodies used in this study.
Antibody

Source

Dilution

Rabbit anti-PRCD

Lab generated

1:1,000

Mouse anti-Rhodopsin (4D2)

Gift from R. Molday, Univ. British Columbia

1:2,000

Mouse anti-GAPDH

Proteintech, 60004-1-Ig

1:10,000

Rabbit anti-PDE6b

Thermo Fisher Scientific, PA 1-722

1:2,000

Rabbit anti-GNAT1

Proteintech, 55167-1-AP

1:2,000

Rabbit anti-ROM1

Gift from G. Travis, UCLA

1:2,000

Rabbit anti-PRPH2

Gift from G. Travis, UCLA

1:2,000

Sheep anti-RGS9

Gift from M. Sokolov, WVU

1:5,000

Rabbit anti-GC-1

Gift from V. Ramamurthy, WVU

1:2,000

Table 2.2. Relative population of regular and irregular discs observed in WT and PrcdKO mice across ages (P30 and P120).

Mice

Regular disc (%)

Irregular disc (%)

WT (P30)

93

7

WT (P120)

92

8

Prcd-KO (P30)

69

31

Prcd-KO (P120)

52

48

89

90
106 ± 98
67 ± 38

P120 Prcd-KO, irregular (n = 48)

106 ± 82

P30 Prcd-KO, regular (n = 61)

P120 Prcd-KO, regular (n = 53)

118 ± 83

P120 WT (n = 47)

81 ± 59

121 ± 75

P30 WT (n = 42)

P30 Prcd-KO, irregular (n = 27)

Number

Parameter value

113 ± 47

167 ± 56

158 ± 43

182 ± 44

191 ± 64

183 ± 42

Density (µm-2)

Nanodomains of rhodopsin

8454 ± 5417

12290 ± 11434

8582 ± 6621

12089 ± 10465

13857 ± 11177

13642 ± 8848

Number

13497 ± 3991

18345 ± 5297

16059 ± 4276

20494 ± 4658

20828 ± 4171

20346 ± 4171

Density (µm-2)

Rhodopsin molecules

Table 2.3. ROS disc properties of 129/SV-E wild-type (WT) and Prcd-KO mice across ages (P30 and P120).

2.9 Supplementary information

Supplementary methods

RNA extraction, cDNA synthesis, and quantitative RT-PCR
Total RNA from P30 and P120 retina from WT and Prcd-KO animals was purified with
TRIzol reagent (Thermo Fisher Scientific) according to manufacturer’s protocols. RNA
concentration was evaluated using a NanoDrop spectrophotometer (ND-1000, Thermo
Fisher Scientific). First strand cDNA synthesis was carried out using the RevertAid First
Strand cDNA Synthesis Kit (Thermo Fisher Scientific) using Oligo (dT)18 primer and 2.5
µg of purified total RNA per 20 µl of reaction volume. Each cDNA was diluted 10-fold with
nuclease-free water before qRT-PCR. The qRT-PCR reactions were prepared using
qPCR Brilliant II SYBR mastermix with ROX (Agilent), 150 nM of each primer, and cDNA
from reverse transcription. To prime the cDNA synthesis, the reactions were performed
according to the manufacturing instructions using a Stratagene Mx3000P real-time PCR
system. Data was acquired using the MxPro QPCR software (Agilent). Each sample (n =
3) was run in triplicate and averaged to produce a single data point. Rhodopsin mRNA
levels were analyzed using the primers SK254F (GAATCACGCTATCATGGGTGTGG)
and

SK255R

(ATGACAAAGGATTCGTTGTTGACC).

Relative

rhodopsin

gene

expression was evaluated by normalization to the levels of the reference genes Hmbs
(hydroxymethylbilane synthase) and Ywhaz (tyrosine 3-monooxygenase/tryptophan 5monooxygenase activation protein, zeta polypeptide). Hmbs levels were quantified using
the

primers

SK258F

(GTTTACCAAGGAGCTAGAAAACGC)
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and

SK259R

(GTGAAAGACAACAGCATCACAAGG). Ywhaz transcript was amplified using the
primers

SK260F

(GTTGTAGGAGCCCGTAGGTCATCG)

(GCTTTCTGGTTGCGAAGCATTGGG).
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and

SK261R

Supplementary Figure S2.1. Depiction of mutations in Prcd-KO mice by
CRISPR/Cas9 genome editing. The amino acid sequence of (a) WT PRCD protein from
129/SV-E mice compared to Prcd-KO founder lines (b) 1738 with a 1 bp deletion, (c) 1734
with a 14 bp deletion, and (d) 1748 with a 71 bp deletion. Red represents the frameshift
mutation, green represents a start codon, and asterisks represent an early stop codon.
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Supplementary Figure S2.2. Uncropped data corresponding to Figure 1B. Validation
of Prcd-KO animal model. Lysate from both Prcd-KO and WT littermate control retina at
P30 and P100 were subjected to western blot analysis and probed for (A) PRCD,
progressive rod-cone degeneration and (B) GAPDH (served as a loading control). Please
note that samples were loaded in duplicate.
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Supplementary Figure S2.3.

Normal levels of major photoreceptor specific

proteins in Prcd-KO retina. Lysate from both Prcd-KO and WT littermate control retina
were subjected to western blot analysis. Blots were probed for several phototransduction
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and OS-disc specific proteins at P30 and P100 with antibodies against (A) ROM1, rod
outer segment membrane protein-1, (B) PRPH2, peripherin 2, (C) GC-1, guanylate
cyclase-1, (D) GNAT1, rod transducin a, (E) PDE6b, phosphodiesterase-6 subunit beta,
(F) RGS9, regulator of G-protein signaling-9. GAPDH served as a loading control (as
shown in Supplementary Fig. S2.2). Please note that Supplementary Fig. S2.4A-D were
loaded in duplicate.
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Supplementary Figure S2.4. No alteration in rhodopsin gene expression at P30 and
P120. WT and Prcd-KO rhodopsin mRNA levels are comparable at (A) P30 and (B) P120.
Rho gene expression was normalized to mRNA levels of the reference genes Ywhaz and
Hmbs. Data are represented as mean relative Rho expression (n=3, unpaired two-tailed
t-test). (Ymhaz; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation
protein, zeta polypeptide, and Hmbs; hydroxymethylbilane synthase).
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Supplementary Figure S2.5. Localization of rhodopsin and peripherin-2 in PrcdKO retina at P30. Cross-sections from Prcd-KO and WT littermate controls were
subjected to immunofluorescent staining with antibodies against the OS disc rim-specific
protein PRPH2 (green) and the OS disc lamellae protein RHO (red) at P30. Scale bar =
20 µm
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Supplementary Figure S2.6. Defective photoreceptor OS ultrastructure of Prcd-KO
retina at P60. (A) Representative TEM images of WT and (B) Prcd-KO photoreceptor
OS cross-sections at P60. (C-E) Prcd-KO ROS displayed some disorganized disc
membranes, vertically aligned stacks of enlarged disc membranes, and disrupted OS with
disc membranes aligned in a vertical and perpendicular shape. (F) Prcd-KO cross
sections also revealed many photoreceptors with normal OS structure with properly
stacked disc membranes. Inlet boxes enlarged from Supplementary Fig. S2.6B (C-F).
Scale bar = 2 µm.
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3.1 Abstract
The photoreceptor outer segment (OS) is a highly modified primary cilium, which serves
as the light-sensing compartment of the cell. The OS contains stacks of double
membranous discs which house proteins required for phototransduction. Many of these
proteins must undergo lipidation in order to properly traffic and associate with the disc
membranes in the OS, such as the rod-specific G-protein coupled receptor complex,
rhodopsin, and the phosphodiesterase-6 (PDE6) heteromeric complex. Unlike other posttranslational lipid modifications, S-palmitoylation is reversible. This means that in addition
to general roles of lipidation such as membrane association, trafficking, and proteinprotein interactions, cycles of palmitoylation and depalmitoylation of a protein can be
implicated in dynamic processes such as ion channel activity or signal transduction. In
this study, we have utilized acyl resin-assisted capture (acyl-RAC) and mass
spectrometry in order to isolate and identify novel proteins in the retina which undergo Spalmitoylation. From the pool of candidate proteins, we have found and validated that the
b2-subunit of the Na+, K+-ATPase (ATP1B2) is post-translationally lipid modified by
palmitoylation. Furthermore, we evaluated ATP1B2 palmitoylation using mass-tag
labeling (acyl-PEG exchange). Using palmitoylation prediction software (GPS-Palm) and
mass spectrometry, we were able to identify that ATP1B2 is palmitoylated on its 10th
amino acid, Cys10. Plasmid constructs expressing WT and C10A mutant ATP1B2 were
injected into the subretinal space of neonatal mice. Injected retina subjected to acyl-RAC
and western blot analysis show that a C10A mutation leads to loss of palmitoylation of
ATP1B2. Altogether, this study utilizes a myriad of well-established techniques in order
to identify novel proteins which undergo palmitoylation, including ATP1B2.
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3.2 Introduction
Many

photoreceptor-specific

proteins

involved

in

phototransduction

are

post-

translationally lipidated, including transducin, phosphodiesterase 6 (PDE6), and
rhodopsin1,2. Lipidation of proteins has proven to be an important regulator of proteinmembrane and protein-protein interactions, protein stability, trafficking, and enzymatic
activity3. Several types of lipids can be covalently linked to proteins, including isoprenoids
(prenylation and geranylgeranylation), phospholipids, sterols, glycosylphosphatidyl
inositol (GPI) anchors, and fatty acids (N-myristoylation and S-palmitoylation)4.

The a-subunit of rod transducin (Gat1) is acylated on its N-terminus by various fatty acids
including myristate5,6. Interestingly, the level of hydrophobicity of the attached fatty acid
alters the light-induced mobility of Gat1 from the photoreceptor OS to the inner segment
(IS), a process known as transducin translocation7. Additionally, the catalytic subunits of
rod PDE6 are heterogeneously prenylated. The a-subunit is farnesylated while the bsubunit is geranylgeranylated at the C-terminal CaaX motif8. Both of these lipid
modifications are important for efficient trafficking and membrane attachment of PDE6 in
the outer segment (OS)8. Rhodopsin, the highly abundant G-protein coupled receptor
(GPCR) in rod photoreceptors, is S-palmitoylated on two neighboring cysteine
residues(Cys322 and Cys323)2,9; these lipids are important for stabilization and
dimerization-dependent raftophilicity of rhodopsin10,11.

Palmitoylation is a post-translational lipid modification which involves attachment of a 16carbon fatty acid (palmitate) to cysteine residues on a protein12. Unlike many lipid
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modifications, palmitoylation is unique in that it is reversible. A family of DHHC-motif
containing palmitoyl acyl-transferases (DHHC-PATs) catalyze the addition of palmitate to
cysteine residues on a protein, while palmitoyl-protein thioesterases (PPTs) depalmitoylate proteins13,14,15. Palmitoylation is important for myriad biological functions,
including membrane association, protein-protein interactions, protein maturation, and
localization to the plasma membrane or specific membrane microdomains14-17. Due to its
reversible nature, palmitoylation plays a role in several dynamic processes including
signaling and ion channel activity18,19. Several experimental methods for the detection
and quantification of protein palmitoylation have been developed20-24.

Due to the dynamic nature of protein palmitoylation and the high number of processes
which must be tightly regulated in the extremely metabolically active retina, our lab was
interested in identifying retinal proteins which undergo S-palmitoylation. In the current
study, our lab utilizes acyl-resin-assisted capture (acyl-RAC) and mass spectrometry to
isolate and identify palmitoylated proteins in the retina. From the pool of candidate
palmitoylated proteins, we have discovered and validated through several additional
methods that the b2-subunit of the retinal Na+,K+-ATPase is palmitoylated.

The Na+,K+-ATPase is an integral membrane protein which exists as a heterodimer
comprised of an a- and a b- subunit and functions as an ion pump in all cells25,26. The asubunit is the catalytic subunit, whereas the b-subunit facilitates the maturation and
trafficking of the holoenzyme to the plasma membrane27. The predominantly expressed
subunit isoforms of the Na+,K+-ATPase in the retina are a3 (ATP1A3) and b2 (ATP1B2),
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and are together often referred to as the retinal Na+,K+-ATPase28,29. ATP1B2 has been
shown to play a crucial role in photoreceptor maintenance, although this role still remains
unclear29-33. Here, we show that ATP1B2 is palmitoylated on Cys10, a cysteine residue
and post-translational lipid modification unique to ATP1B2 when compared to the other
Na+,K+-ATPase b-subunit isoforms. Although we identify a novel post-translational
modification of ATP1B2 in the retina, further work must be done to determine the specific
functional consequences of retinal ATP1B2 palmitoylation.

3.3 Results

3.3.1 Identification of palmitoylated proteins in the retina using acyl-RAC followed
by mass spectrometry
In order to comprehensively identify retinal proteins which are palmitoylated, we utilized
an assay known as acyl resin-assisted capture (acyl-RAC), which takes advantage of the
reversible thioester linkage between palmitate and the modified cysteine residue (Fig.
1A)20. As the reagent used to bind and capture palmitoylated cysteines is Thiopropyl
Sepharose-6B (TPS-6B) resin, which binds free thiol groups, the first step in the assay is
to incubate retinal lysate under denaturing conditions with methylmethanethiosulfonate
(MMTS) to block any free thiol groups. These free thiol groups represent nonpalmitoylated cysteine residues on proteins.

In the second step after blocking free thiols, palmitoylated cysteine residues are subjected
to treatment with hydroxylamine (NH2OH), which removes palmitate from the protein,
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through cleavage of the thioester bond which holds it to the cysteine residue, creating a
new free thiol group. The third step is to incubate the samples with the TPS-6B resin in
order to capture the newly formed free thiol groups formed after cleavage of palmitate by
NH2OH. Finally, in the fourth step, proteins which bind to the resin are eluted with a
reducing agent such as dithiothreitol (DTT). To ensure proper blocking and to serve as a
negative control, a portion of retinal lysate was not treated with hydroxylamine (-NH2OH).
Both treated (+NH2OH) and negative control (-NH2OH) samples were sent for mass
spectrometry (LC-MS/MS) to identify candidate proteins which are palmitoylated in the
retina.

A total of 803 proteins which were present in the palmitoylated fraction (+NH2OH elute)
were chosen from the mass spectrometry data based on their spectral counts to analyze
further. These proteins were cross-referenced with SwissPalm, a comprehensive online
database which compiles data concerning palmitoylation of proteins and proteins
appearing in proteomic studies34. Of our candidate proteins, 64.3% have been identified
in palmitoyl proteome studies but not independently validated, 0.9% have been
independently validated as palmitoylated but not identified in any palmitoyl proteomes,
and 13.2% of proteins have been both validated and reported in palmitoyl proteome
studies previously. Interestingly, 17.8% of proteins identified in our study have not
previously been identified as palmitoylated (Fig. 1B).

To validate our mass spectrometry data, we chose several proteins whose palmitoylation
status is well-documented and confirmed their statuses using western blot.
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Synaptotagmin-2 (SYT2), rhodopsin (RHO), and ADP-ribosylation factor-like protein 13B
(ARL13B) are all proteins which have been validated as palmitoylated or appeared in
other mouse palmitoyl proteomes9,35-37. These proteins all appeared in our mass
spectrometry results as palmitoylated and were also detectable via western blot (Fig. 1C).
As a negative control, we blotted for rod PDE6α, a farnesylated protein (Fig. 1C).
Collectively, these data suggest that acyl-RAC is an effective method to use for the
identification of palmitoylated retinal proteins.

3.3.2 The b2 subunit of the Na+, K+-ATPase (ATP1B2) is palmitoylated in the retina
Of the other candidate proteins which appear in our acyl-RAC/mass spectrometry data,
the one that is of most interest to this study is the β2 subunit of the Na+, K+-ATPase
(ATP1B2). First, we used acyl-RAC and western blot analysis to confirm palmitoylation
of ATP1B2 (Fig. 2A). In this study, GOa, a known palmitoylated protein localized to bipolar
cells, was used as a positive control37. Importantly, when the amino acid sequence of
ATP1B2 is analyzed using a palmitoylation prediction algorithm (GPS-Palm), the 10th
amino acid (Cys10) is predicted to be palmitoylated with a medium confidence score (Fig.
2B)38. Interestingly, when compared to the other β-subunit isoforms of the Na+,K+-ATPase,
Cys10 is unique to ATP1B2 (Fig. 2C). As expected, ATP1B1 was not found to be
palmitoylated (Fig. 2A). Furthermore, Cys10 is conserved across several mammalian
species (Fig. 2C). Although ATP1B2 is heavily glycosylated on the extracellular portion
of the protein and has six additional cysteines implicated in disulfide bonds, palmitoylation
appears to be the only known post-translational modification located on the N-terminus
of the protein (Fig. 2D).
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An additional method known as acyl-PEG exchange was also used to validate the
palmitoylation of ATP1B2 in retina (Fig. 3A)24. In this method, Bond-BreakerTM TCEP is
used to break any disulfide bonds and N-ethylmaleimide (NEM) is used to block all free
cysteines. Once again, hydroxylamine (NH2OH) is used to cleave the thioester bond
attaching palmitate to the palmitoylated cysteine on the protein. Once a new free thiol
group is formed, lysate is incubated with mPEG-maleimide 5kDa. This PEGylated
chemical will then attach to the free thiol group, giving the palmitoylated protein an
additional 5 kDa shift for every residue which is modified when analyzed by western blot.
Our data from retinal lysate reveal a 5 kDa shift of a portion of ATP1B2 in only the treated
(+NH2OH) sample, indicating selective PEGylation and denoted by an asterisk (Fig. 3B).
A fraction of total ATP1B2 is non-PEGylated (denoted as “apo”), indicating the portion of
the retinal pool of ATP1B2 which is not palmitoylated. As a negative control, a sample not
treated with hydroxylamine (-NH2OH) is run alongside the treated sample (Fig. 3B, lanes
1 and 3). PEGylation of the known palmitoylated protein (GOa) and non-PEGylation of a
negative control (PDE6a) confirm the specificity of the acyl-PEG exchange assay.
Collectively, mass-tag labeling of retinal proteins by acyl-PEG exchange further confirms
that Cys10 in ATP1B2 is modified by palmitoylation.

3.3.3 ATP1B2 is palmitoylated on Cys10
Interestingly, aside from the predicted palmitoylated Cys10 residue, all other cysteines in
ATP1B2 have been shown to participate in disulfide bonds (Fig. 2C). To determine the
ATP1B2 residue which is palmitoylated, we utilized mass spectrometry in conjunction with
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carbamidomethylation labeling, a method which has been widely used for identifying
palmitoylated cysteines23. Retinal lysate was subjected to acyl-RAC and eluted samples
were then treated with iodoacetamide, which binds free thiol groups. Alkylation of
iodoacetamide results in covalent addition of a carbamidomethyl group, which gives a
mass difference of 57 Da. Analysis of treated samples by mass spectrometry can
visualize these carbamidomethylated cysteines as residues with increased mass (C+57).
As expected, our mass spectrometry analysis reveals that Cys10 in ATP1B2 is modified
(Fig. 4).

3.3.4 A C10A mutation in ATP1B2 results in loss of palmitoylation in vivo
In order to confirm palmitoylation of ATP1B2 on its N-terminal Cys10 residue in vivo, we
generated two plasmid constructs in a pCAG vector under a chicken b-actin promoter.
One construct expresses wild-type mouse HA-tagged ATP1B2, while the other expresses
mouse HA-tagged ATP1B2 with a cysteine to alanine mutation at Cys10 (C10A) (Fig. 5A,
B). Both of these constructs feature an HA tag on the C-terminal end of the protein.
Additionally, our construct has a separate IRES driven EGFP reporter to evaluate
transfection efficiency and protein stability. We injected these constructs into the
subretinal space of neonatal mice at P0 and collected retinal tissue at P21. Uninjected
(contralateral eye), ATP1B2, and ATP1B2-C10A injected retinal lysates were analyzed
using acyl-RAC. Western blot analysis clearly shows that endogenous ATP1B2 and
ectopically-expressed ATP1B2 is palmitoylated, while ATP1B2-C10A is not (Fig. 5C).
These data confirm that ATP1B2 is palmitoylated on Cys10 and that a C10A mutation
results in loss of palmitoylation in vivo.
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3.4 Discussion
Many photoreceptor proteins involved in phototransduction, OS maintenance, and
photoreceptor function require lipidation to participate in their required functions, the
original focus of the current study was to identify a pool of proteins in the metabolically
active retina which undergo palmitoylation. By taking advantage of the unique chemistry
of palmitoylation, our lab employed acyl-RAC and mass spectrometry in order to isolate
and identify proteins in the retina which undergo this post-translational lipid modification.
We utilized the SwissPalm database in order to individually cross reference 803 candidate
proteins from our data against proteins which had been identified in other palmitoyl
proteome studies and proteins which had been validated as palmitoylated.

As expected, many proteins which are ubiquitously expressed in different tissues are also
expressed in the retina, so we did identify a large population of proteins (64.3%) which
had been identified in other palmitoyl proteome studies. There was also a population of
proteins which have not been identified in other palmitoyl proteome studies, but have
been validated (0.9%), likely proteins which are expressed in tissues which have not had
palmitoyl proteomes characterized. Two examples of proteins which fit into this category
would be progressive rod-cone degeneration (PRCD) and rhodopsin. Additionally, there
were proteins which had been both validated and identified in other palmitoyl proteome
studies (13.2%), as well as proteins which have not been placed into either of these
categories (17.8%). From these candidate proteins, we decided to choose one protein
which has also been identified in other palmitoyl proteome studies, but has not yet been
validated – the b-subunit of the retinal Na+,K+-ATPase, ATP1B2. Additionally, we were
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able to determine that ATP1B2 is palmitoylated on its N-terminal cysteine residue at the
10th amino acid position (Cys10) using palmitoylation prediction software and mass
spectrometry.

All isoforms of the b-subunit of the Na+,K+-ATPase (ATP1B1, ATP1B2, and ATP1B3)
contain six cysteine residues located on the extracellular portion of the protein, all of which
have been shown to participate in disulfide bonds27. Two of these disulfide bonds are
crucial for binding the a-subunit, while the other is required for proper enzymatic activity
of the holoenzyme39. Although both ATP1B1 and ATP1B2 contain one additional cysteine,
the extra cysteine in ATP1B1 is located within the transmembrane domain at the 45th
amino acid position (Cys45) and has been shown to undergo glutathionylation40. The
additional cysteine residue located near the N-terminus of ATP1B2 (Cys10) is not only
unique to ATP1B2, but is conserved across several different mammalian species.
Therefore, it is possible that palmitoylation of ATP1B2 plays an important role in
modulating one or more of its functions.

In the retina, the predominantly expressed subunits of the Na+,K+-ATPase are ATP1A3
and ATP1B228,29. Although photoreceptors express ATP1A3, ATP1B2, and ATP1B3,
ATP1B2 has been shown to play a crucial role in photoreceptor maintenance, as 50% of
photoreceptors degenerate by P17 in retina lacking ATP1B231-35. Furthermore, another
animal model has been characterized which lacks ATP1B2, but expresses ATP1B1 in its
place (b1/b2 knock-in). While expression of ATP1B1 in photoreceptors helps to delay
degeneration, 50% of photoreceptors still degenerate by 4 months of age in the absence
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ATP1B233. These studies outline an apparent requirement of ATP1B2 expression in the
retina to ensure photoreceptor maintenance and survival, yet the unique requirement of
this b-subunit isoform of the Na+,K+-ATPase remains unclear. While there are structural
similarities between the b-isoforms of the Na+,K+-ATPase, the overall sequence homology
between the three is relatively low. These differences in structure give unique properties
to each isoform, granting variety in their involvement in different cellular functions.
Palmitoylation provides a unique feature to the b2-subunit isoform which the other
isoforms lack.

One possible role for palmitoylation of ATP1B2 is proper targeting and subcellular
localization of the Na+,K+-ATPase to the IS. In photoreceptors, the Na+,K+-ATPase
exclusively localizes to the IS, where proteins are synthesized. Due to the high amount
of ATP utilized by the Na+,K+-ATPase, it is believed that this specific localization to the IS
is required in order to ensure that ATP can be funneled to and utilized by the OS during
light stimulus41,42. In the dark when phototransduction is dormant, the Na+,K+-ATPase
uses the majority of ATP, but this trend shifts in the light when phototransduction is
actively cycling in the OS41. Many phototransduction proteins, such as rhodopsin, are
synthesized in the IS and must be trafficked to the OS to participate in their proper function.
However, the connecting cilium bridging the IS and OS restricts which proteins are able
to pass. Studies in frog photoreceptors have shown that rhodopsin is able to diffuse from
the OS to the IS when this barrier is compromised, yet the Na+,K+-ATPase remains
confined to the IS43. To date, only one other protein (ankyrin-B) has been shown to
interact with ATP1B2 and demonstrate a role in securing the Na+,K+-ATPase to the IS
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cytoskeleton, however only a small amount of ankyrin-B has been shown to
immunoprecipitate with the Na+,K+-ATPase in retina41,44. Due to the implication of
palmitoylation in localization to specific membrane microdomains and subcellular
trafficking, it is possible that palmitoylation of ATP1B2 in photoreceptors could be
important to tether the Na+,K+-ATPase to the IS plasma membrane, ensuring proper
localization to the IS compartment.

As mentioned, the amino acid sequences and post-translational modifications of the bsubunit isoforms (b1, b2, and b3) vary greatly, contributing to their unique cellular
functions. Interestingly, of the b-subunit isoforms, the transmembrane alpha helix in
ATP1B2 has been shown to have a tilt angle which is 5° different compared to ATP1B1
and ATP1B345. This tilt angle is thought to alter the interaction between ATP1B2 and its
bound catalytic (a-) subunit, which may influence Na+,K+-ATPase activity45. In fact,
studies show that pumps containing ATP1B2 have a lower affinity for K+ ions46. Due to
the reversibility of S-palmitoylation, this post-translational lipid modification carries
implications in dynamic biological processes such as signaling and ion channel activity.
Considering the unusually high activity of the Na+,K+-ATPase in photoreceptors and the
fact that loss of the b2-subunit of the retinal Na+,K+-ATPase leads to photoreceptor
degeneration, it is apparent that regulation of Na+,K+-ATPase activity would be extremely
important for retinal health.

Interestingly, many tissues express a g-subunit of the Na+,K+-ATPase which binds the
Na+,K+-ATPase holoenzyme and alters the pump’s ion affinities or its kinetic properties,
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yet no g-subunit has yet been identified in the retina47. It is quite possible that
palmitoylation of ATP1B2 could also alter the structural conformation of the retinal Na+,K+ATPase enough to alter its affinities for Na+ and K+, or otherwise modulate the kinetic
properties of pump activity. In this role, palmitoylation would essentially serve as a quasig-subunit for the retinal Na+,K+-ATPase.

In conclusion, we have identified a previously unknown post-translation modification of
ATP1B2 by palmitoylation in the retina. Using several experimental approaches, we have
verified this modification and identified it on Cys10, which we provide evidence is
palmitoylated in vivo. We also employed a palmitoylation gel-shift assay to observe that
a significant portion of retinal ATP1B2 is likely palmitoylated, which likely contributes a
role to one or multiple functions of ATP1B2. While there are several enticing hypotheses
concerning the mechanistic role of ATP1B2 palmitoylation, this specific role remains to
be delineated and is a subject of ongoing and future studies. In general, continued study
of ATP1B2 and other palmitoylated proteins in the mammalian retina promises to increase
our collective understanding of this unique post-translational modification and its evergrowing list of important biological roles.
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3.5 Methods

3.5.1 Animals
All experimental procedures involving animals in this study were approved and conducted
in strict accordance with relevant guidelines and regulations by the Institutional Animal
Care and Use Committee at West Virginia University.

3.5.2 Cloning
Plasmid constructs encoding wild type and mutant (C10A) mouse ATP1B2 with a Cterminal epitope hemagglutinin-tag (HA) were synthesized as followed. Epitope-tagged
gene fragments were generated using PCR and custom-made primers (see Table 3.1)
and subsequently ligated into a SalI-HF/BamHI digested (New England BioLabs) pCAG
vector containing a CAG promoter and in-frame IRES-EGFP sequence.

3.5.3 Acyl-RAC Isolation of Palmitoylated Proteins
Palmitoylated proteins or transiently transfected hRPE1 cells were assessed by acyl-RAC
as described previously20,37. Retinas were homogenized in ice-cold lysis buffer (25 mM
HEPES, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM HDSF, plus protease and
phosphatase inhibitors) by sonication. Lysate was then treated with 1% Triton-X-100 for
20 minutes at 4°C on a rotator. Next, lysate was centrifuged at 500 xg for 3 minutes and
supernatant was transferred to a new tube to block free cysteine residues with blocking
buffer (100 mM HEPES, pH 7.5, 1 mM EDTA, 2.5% SDS, and S-methyl
methanethiosulfonate). Blocking was carried out for 18 minutes at 40°C by vortexing
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every 2 minutes. Proteins were precipitated using ice-cold acetone for 30 minutes at 20°C and subsequently centrifuged for 20 minutes at 4°C. Protein pellets were washed
four times with 70% ice-cold acetone and then air dried at room temperature for 15-20
minutes. After resuspension with 600 µl of binding buffer (100 mM HEPES, pH 7.5, 1 mM
EDTA, 1% SDS), the lysate was split into two fractions. Both fractions were added to 40
µl of pre-washed Thiopropyl Sepharose 6B beads (GE Healthcare). One fraction
(+NH2OH) was treated with 40 µl of 2M hydroxylamine, pH 7.5 (Sigma), while the other (NH2OH) was treated with 40 µl of NaCl (control). Samples were incubated for 2 hours at
room temperature and beads were washed with binding buffer four times. Bound proteins
were then eluted with 10 mM DTT and further analyzed by LC/MS mass spectrometry
and western blotting.

3.5.4 Proteomic analysis
As described earlier, retinal lysate was subjected to acyl-RAC and samples were eluted
with 100 µl of elution buffer containing 10 mM DTT. Two samples treated with and without
hydroxylamine (NH2OH) were concentrated by lyophilization. The lyophilized protein
samples were reconstituted with 1X PBS at an equal concentration for both treated and
untreated (+/- NH2OH) for LC-MS/MS mass spec analysis. Three independent analyses
from two different places, 1) Protea Biosciences, (Morgantown, WV) and 2) Harvard
University mass spectrometry facility were performed.

3.5.5 Western blotting
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To assess protein levels, retina or cells were homogenized on ice by sonication (Microson
Ultrasonic cell disruptor; 3 pulses, 3 seconds at power setting 10) in 1X phosphate
buffered saline (PBS) with protease and phosphatase inhibitors. A NanoDrop
spectrophotometer (ND-1000, Thermo Fisher Scientific) was utilized to quantify protein
concentration. To each sample before boiling for 5 minutes, 5X Laemmli buffer was added
with 5% b-mercaptoethanol. An equal concentration of each sample was loaded and
separated by SDS-PAGE in a 4-20% tris-glycine precast gel (4–20% Mini-PROTEAN
TGX, Bio-Rad, Hercules, CA, USA) and then transferred to an Immobilon-FL PVDF
membrane (Immobilon-FL, Millipore, Burlington, MA, USA). Membranes were then
blocked for 1 hour at room temperature using Odyssey Blocking Buffer (LI-COR
Biosciences, Lincoln, NE, USA) prior to being incubated with primary antibodies (see
Table 3.2 for full list of antibodies used). Primary antibody was left on membranes for 2
hours at RT or overnight at 4°C on a bidirectional rotator. Membranes were then washed
three times in 1X PBST (1X PBS/0.1% Tween-20) for 5 minutes each at room temperature
prior to being incubated with secondary antibody, goat anti-rabbit Alexa Fluor 680, goat
anti-mouse DyLight 800 or donkey anti-sheep Alexa Fluor 680 (Thermo Fisher Scientific)
for 30 minutes at RT. Blots were washed 3 times in 1X PBST before being scanned using
an Odyssey Infrared Imaging System. Protein density was measured according to
manufacturer’s instruction (LI-COR Biosciences, Lincoln, NE, USA).

3.5.6 Carbamidomethylation of acyl-RAC retinal samples
This process was completed at Protea Biosciences, Inc. Morgantown, WV. The
concentrated samples from acyl-RAC treated with or without NH2OH were incubated with
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50 mM iodoacetamide in 50 mM ammonium bicarbonate for 10 min at RT. The reaction
was stopped by addition of matrix (sinapinic acid in 30% acetonitril, 0.3% TFA) and
analyzed by MALDI-TOF, and LC-MS/MS. The peptides were identified by MS/MS
spectra searched against using the Scaffold4 software search engine. The samples were
processed to identify cysteines modified by carbamidomethylation. The precursor mass
tolerance for carbamidomethylation or palmitoylation on Cys, Acetyl on Protein Nterminus and oxidation of Met were used by setting fragment ion mass tolerance to 0.5
Da. Iodoacetamide only affected the peak corresponding to the deacylated ATP1B2 at Nterminal cysteine 10, with an expected increase of 57 Da corresponding to a
carbamidomethylation of the free sulfhydryl group.

3.5.7 Acyl-PEG exchange
Experiment was conducted using a modified protocol which was previously described24.
2 retina were suspended in 150 µl lysis buffer (1X TEA buffer [5 mM Triethanolamine, 15
mM NaCl, pH 7.3], 4% SDS, protease inhibitor, Pierce universal nuclease, and PMSF)
and sonicated. After addition of EDTA (final concentration 5 mM), total protein
concentration was assessed using a NanoDrop spectrophotometer (ND-1000, Thermo
Fisher Scientific). Next, 2 µg of total protein was transferred to a clean tube and treated
with neutralized Bond-BreakerTM TCEP (Thermo Fisher Scientific) for 30 minutes at room
temperature under constant rotation in order to break any disulfide bonds. Lysate was
next treated with 25 mM N-ethyl maleimide (NEM) for 2 hours at room temperature with
nutation in order to block any exposed cysteine residues. To remove TCEP and NEM,
protein was next precipitated three sequential times as described by Percher et al using
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methanol, chloroform, and water at a 4:1.5:3 ratio relative to sample volume24. After
precipitation, precipitated protein was dried using a vacuum centrifuge (Vacufuge,
Eppendorf*) for 10 minutes at room temperature and then resuspended in 60 µl of 1X
TEA buffer with 4% SDS and 4 mM EDTA. Next, the sample was split into two-30 µl
fractions. One fraction (+NH2OH) was treated with 90 µl of hydroxylamine (prepared in
1X TEA buffer with 0.2% Triton-X-100), while the other (-NH2OH) was treated with 90 µl
of 1X TEA buffer with 0.2% Triton-X-100 (control). Samples incubated for 1 hour at room
temperature under nutation with hydroxylamine in order to cleave thioester bond (remove
palmitoylation). After incubation, proteins were precipitated (see above) in order to
remove all traces of hydroxylamine present. Next, samples were resuspended in 30 µl of
1X TEA buffer with 4% SDS and 4 mM EDTA and treated with 1 mM mPEG-maleimide
(5 kDa) for 1 hour at room temperature (under nutation) to give a mass shift difference to
any cysteine residues which were modified by palmitoylation. After a final protein
precipitation, samples were resuspended in 1X Laemmli buffer (200 µl 5X Laemmli in 800
µl 1X TEA buffer/4% SDS) with 5% b-mercaptoethanol and incubated at 95°C for 5
minutes. Samples were then analyzed by SDS-PAGE electrophoresis and western blot.

3.5.8 Subretinal injection
Wild-type and mutant (C10A) Atp1b2 plasmid DNA (5.0 µg/µl) was purified and prepared
for injection by adding 0.1% fluorescein sodium (100 mg/ml; AK-FLUOR). Surgery was
performed under a Leica M80 microscope (Leica Microsystems). Neonatal mice
(postnatal day 0) were anesthetized by hypothermia and an incision was made using a
255/8-gauge needle (BD Biosciences) to open the future eyelid. Next, a 301/2-gauge needle
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is used to make a small hole in the sclera, just outside the border of the cornea. Using a
Hamilton syringe, 33-gauge blunt end needle (Hamilton Company) is placed through the
hole which was made and 0.25-0.5 µl of plasmid DNA was injected into the subretinal
space. Plasmid DNA was next electroporated (five pulses of 80V, 50 ms duration, 950
ms interval) by Tweezer-type electrodes (BTX model 520, 7mm diameter). Injected and
contralateral (control) retina were collected 21 days later and subjected to acyl-RAC
followed by western blot analysis.
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3.7 Figures and Figure Legends

Figure 3.1. Identification of palmitoylated proteins in the murine retina. (A) Scheme
demonstrating the experimental procedure for acyl resin-assisted capture, or acyl-RAC.
–SH groups represent free thiol groups. MMTS = methylmethanethiosulfonate, NH2OH =
hydroxylamine, TPS = Thiopropyl Sepharose-6B resin, DTT = dithiothreitol. (B) Pie chart
demonstrating categorization of 803 proteins which were chosen from the mass
spectrometry data after following cross-referencing with the Swiss Palm database of
known palmitoylated proteins. (C) Immunoblot analysis of acyl-RAC retinal samples
validates palmitoylation of several previously identified proteins which are palmitoylated,
including synaptotagmin-2 (SYT2), rhodopsin (RHO), and ADP-ribosylation factor-like
protein 13B (ARL13B). Rod phosphodiesterase 6 subunit alpha (PDE6α) was used as a
negative, non-palmitoylated control. T = total, U = unbound, E = elute
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Figure 3.2. The retinal Na+,K+-ATPase b2-subunit is palmitoylated in the retina. (A)
Immunoblot analysis of retinal lysate subjected to acyl-RAC demonstrating palmitoylation
of ATP1B2, but not its homologue, the b1-subunit isoform of the Na+,K+-ATPase
(ATP1B1). GOa is a known palmitoylated protein and was analyzed as a positive control.
T = total, U = unbound, E = elute. (B) GPS-Palm prediction software shows a
palmitoylation prediction score for each cysteine residue in ATP1B2, with Cys10 receiving
a medium confidence score as the predicted palmitoylated residue. (C) Scheme
demonstrating that Cys10 is unique to ATP1B2 among its other b-subunit isoform
homologues and is conserved across several mammalian species. (D) Scheme
demonstrating the known structural domains and post-translational modifications of
mouse ATP1B2.
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Figure 3.3. Acyl-PEG exchange confirms palmitoylation of ATP1B2 in the retina. (A)
Scheme demonstrating the methodology behind acyl-PEG exchange. –SH groups
represent free thiol groups. NEM = N-ethyl maleimide, NH2OH = hydroxylamine, mPEGmal 5 kDa = methoxy PEG maleimide. (B) Immunoblot analysis of retinal lysate subjected
to acyl-PEG exchange demonstrating palmitoylation of ATP1B2.

GOa is a known

palmitoylated protein and was analyzed as a positive control. Rod phosphodiesterase 6
subunit alpha (PDE6α) was used as a negative, non-palmitoylated control. Palmitoylated
proteins which are PEGylated are indicated by asterisks in the +NH2OH fraction, while
proteins labeled apo represent the non-palmitoylated fraction of the protein which is nonPEGylated.
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Figure 3.4. MS/MS spectra of carbamidomethyl modified cysteine in ATP1B2
peptides. S-palmitoylation sites are labelled with carbamidomethyl demonstrates that is
Cys10 ATP1B2 is palmitoylated. Carbamidomethylation of cysteine residues indicated as
C+57, asterisks in red (MS/MS spectra shown in both directions indicate
carbamidomethylation of Cys10).
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Figure 3.5. A C10A mutation in ATP1B2 results in loss of palmitoylation. (A) Scheme
demonstrating the lab-generated plasmid constructs of HA-tagged wild-type and mutantC10A ATP1B2 in a pCAG-IRES-EGFP vector. (B) Immunoblot analysis of retinal lysate
following subretinal injection and electroporation of WT- and C10A- ATP1B2 following
acyl-RAC. HA = hemagglutinin tag. GOa is a known palmitoylated protein and was
analyzed as a positive control. Green fluorescent protein (GFP) was used as a negative,
non-palmitoylated control. T = total, U = unbound, B = bound.
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3.8 Tables

Table 3.1. List of primers used for cloning of WT and C10A ATP1B2 constructs
Primer name

Sequence

SK114 – ATP1B2 pCAG

5’ – CTG CGA TCG GTC GAC CCG GTC GCC ACC ATG

forward, SalI

GTC ATC CAG AAA GAG – 3’

SK139 – C10A-ATP1B2

5’ – ATG GTC ATC CAG AAA GAG AAG AAG AGC GCC

mutant pCAG forward

GGG CAG GTG GTT GAG GAG TGG AAG GAG – 3’

SK115 – ATP1B2 pCAG 5’ – GCG CTC GGA TCC TCA AGC GTA ATC TGG AAC
reverse, HA tag, BamHI

ATC GTA TGG GTA GGT TTT GTT GAT CCG GAG – 3’

Table 3.2. List of primary antibodies used in this study.
Antibody

Source

Dilution

Rabbit anti-ATP1B2

Proteintech, #22338-1-AP

1:2,000

Rabbit anti-GNAO1

Proteintech, #12635-1-AP

1:2,000

Rat anti-HA

Roche, #11867423001

1:2,000

Mouse anti-GFP

Proteintech, #66002-1-Ig

1:2,000

Rabbit anti-PDE6a

Thermo Fisher, #PA1-720

1:2,000

Rabbit anti-ATP1B1

Millipore Sigma, #05-382

1:2,000

Mouse anti-SYT2

Santa Cruz Biotechnology, #sc-136089

1:200

Mouse anti-RHO (4D2)

Gift from R. Molday, Univ. British Columbia

1:2,000

Rabbit anti-ARL13B

Gift from V. Ramamurthy, WVU

1:2,000
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Chapter 4 – Conclusions and Future Directions
89217-468

The key proteins studied in Chapter 2 and Chapter 3 of this dissertation are directly linked
to either maintenance of photoreceptor structure (PRCD) or to proper photoreceptor
function (ATP1B2), both of which are required for visual perception and have been
extensively shown to influence one another. Photoreceptor neurons possess many
unique structural features which are needed for their intrinsic function, including
specialized cellular compartments such as the OS, IS, and synapse. These distinct
compartments serve to create hubs for localization of specific proteins and to segregate
proteins involved in different cellular processes. Any defects in these unique structural
features of photoreceptors lead to flaws in function and dysregulation of photoreceptor
function often leads to morphological abnormalities.

4.1 Conclusions and Future Directions – Chapter 2
PRCD is a small, 54 amino acid, photoreceptor-specific protein which is localized to
photoreceptor disc membranes1. The only known binding partner of PRCD is rhodopsin,
which initiates visual transduction in rod photoreceptors, although the significance of this
interaction is not well understood2. Mutations in PRCD are associated with slow and
progressive photoreceptor degeneration, characterized by disoriented OS disc
membranes and disorganized OS, and are linked to RP3-7. An interesting hallmark of
PRCD-associated disease is that it is extremely heterogeneous, as demonstrated by the
varying phenotypes observed in different dog breeds carrying a C2Y mutation in PRCD3.
Although we now know that PRCD plays an important role in disc morphogenesis, little is
known regarding how PRCD is specifically involved in this process.
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The objective of the 2nd chapter of this dissertation was to further investigate the role of
PRCD in disc morphogenesis through characterization of our Prcd-KO mouse model,
which was generated using Crispr/Cas9 gene editing. Through the combination of
ultrastructural analysis and electroretinography (ERG) studies, we demonstrated that
rods lacking PRCD show defects in both structure and function beginning at P30. It is
important to note that while these structural and functional changes are observed at P30,
degeneration of photoreceptors does not occur until after P120. Moreover, we
demonstrate that loss of PRCD leads to formation of a population of rod photoreceptor
disc membranes which are packaged with a lower rhodopsin density and with fewer
rhodopsin nanodomains. The number of these disc membranes containing altered
rhodopsin packaging increase from 30% of Prcd-KO discs at P30 to 50% at P120,
indicating that these defects in rhodopsin packaging occur well before degeneration.
Although PRCD and rhodopsin have been shown to interact with one another, these
findings are the first to show any reported changes to rhodopsin prior to degeneration as
a result of loss of PRCD.

Interestingly, even well documented changes to the bioavailability of rhodopsin do not
seem to affect rhodopsin density or number of rhodopsin packaged into disc membranes.
A mouse model under-expressing rhodopsin shows changes to disc diameter and OS
length, but not changes to density or number of rhodopsin8,9. Interestingly, one
environmental variable which does also alter the packing density of rhodopsin is light.
Just as we see in our Prcd-KO mice at P30 and P120, disc membranes from WT mice
housed in constant light for 10 days also have fewer rhodopsin molecules and a lower
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rhodopsin packing density compared to WT mice housed in cyclic light10. Alternatively,
discs from mice which are housed in constant dark for 10 days present with an increased
number of rhodopsin molecules and rhodopsin packing density compared to mice housed
in cyclic light, changes which only continue to increase the longer mice are housed in
constant dark (20 and 30 days)10. Strikingly, these increases in rhodopsin number and
packing density are also associated with improved rod visual function in mice housed in
constant dark after 20-30 days compared to those housed in cyclic light10.

To further elucidate the specific role of PRCD in disc morphogenesis, a future direction
of the lab is to continue our AFM studies through analysis of disc membranes from PrcdKO mice housed in constant light and dark. Animals with mutations in or lacking PRCD
have shown to exhibit delayed renewal and phagocytosis of photoreceptor OS4.
Furthermore, renewal rates of OSs have been shown to be slower in the dark (0.63
µm/day) and faster in the light (0.97 µm/day), compared to cyclic light (12hr light/12hr
dark; 0.83 µm/day)11. It is possible that housing mice in constant dark could help to
postpone onset of PRCD-associated disease, as renewal rates in the dark are already
slower, potentially giving photoreceptors lacking PRCD more time to meet OS renewal
and phagocytosis needs. Alternatively, knowing that mice housed in constant dark adapt
by increasing the rhodopsin packing density and number of rhodopsin molecules which
are incorporated into discs, it is also possible that housing mice in constant dark could
exacerbate PRCD-associated disease if PRCD is needed for regulation of rhodopsin
packaging into newly forming discs.
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Multiple outcomes are also possible for Prcd-KO mice housed in constant light. Only a
portion of irregular disc membranes containing a reduced number and packing density of
rhodopsin are present in Prcd-KO mice at P30 (30%) and P120 (50%). As WT mice
housed in constant light adapt by decreasing rhodopsin packing density and number of
rhodopsin molecules, it is possible that PRCD-associated disease could be slowed due
to the reduced number of rhodopsin being packaged into discs. More likely, housing mice
in constant light would be very detrimental to photoreceptor health, as increased need for
renewal would not be able to be met by Prcd-KO photoreceptors with slowed OS renewal
and phagocytosis. Furthermore, there is a strong likelihood that many discs would contain
even fewer molecules of rhodopsin with an even lower rhodopsin packing density if PRCD
is truly required for regulation of rhodopsin incorporation into disc membranes.

To determine the consequences of long-term light or dark exposure to Prcd-KO
photoreceptors, I propose that we compare dark-reared Prcd-KO animals to Prcd-KO
animals housed in cyclic light and in constant light from birth until they reach P30 (cohort
I) and P120 (cohort II). I propose that we do ultrastructural analysis to examine
photoreceptor structure and electroretinography (ERG) to measure photoreceptor
function. Furthermore, it would be important to measure renewal rates in these animals,
which could be accomplished by immunofluorescent staining and quantification of the
number of phagosomes present in the RPE 12. Rhodopsin protein levels and mRNA levels
would be assessed as described in Chapter 2 and AFM analysis would be utilized in order
to determine alterations to rhodopsin packaging in disc membranes from all three groups.
WT mice would also be examined as controls. These studies could help to provide further
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insight into the mechanistic role of PRCD in disc morphogenesis, and more specifically,
in mediating incorporation of rhodopsin molecules into disc membranes.

Another interesting phenotype which varies between different animal models with
mutations in PRCD is the presence of vesicular profiles in the interphotoreceptor
space4,5,7. Although these vesicles are a hallmark of PRCD-associated disease in
miniature poodles, they are absent from English cocker spaniels3. The other two mouse
models lacking PRCD, which are studied in a C57BL6/J background, see evidence of
these vesicles accumulating in the interphotoreceptor space4,5. However, our Prcd-KO
mouse model was studied in a 129/SV-E background and we do not see significant
evidence of extracellular vesicles. Allon et al utilizes classic methods of fixation for TEM
and ultrastructural analysis to see these structures, while Spencer et al uses a specific
technique for fixation which helps to ensure staining of nascent structures, such as newly
forming discs at the base of the OS4,5. To determine if this discrepancy in our Prcd-KO
mouse model is due to phenotypic variations between mouse strains or a result of
improper fixation of these newly formed structures, our lab plans to use a similar method
of fixation to study ultrastructure and search for the presence of these vesicles in our
mouse model.

Finally, another interest of the lab is to further study the predicted structural domains in
PRCD to help to further elucidate its role in the photoreceptor. For such a small protein
(54 amino acids), PRCD has three predicted structural domains including a
transmembrane or hydrophobic domain, polybasic region, and VxPx motif2,13.
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Interestingly, each of these structural domains is closely associated with at least one
mutation that is linked to RP. Our lab plans to generate plasmid constructs of each
disease-associated mutation in PRCD within a pCAG-IRES-GFP vector as described
previously13. The first mutation, which is located before the hydrophobic region of PRCD
is C2Y, and has been studied extensively in canines3,14,15. PRCD-C2Y has been shown
to be mislocalized to the IS in vivo and protein stability is severely reduced2,13. The major
difference in PRCD-C2Y protein is loss of palmitoylation, a post-translational lipid
modification linked to many biological processes including protein stability13,16.

Other mutations which have not been studied in depth include the R17C and R18X
mutations in the polybasic region of PRCD, as well as a P25T mutation in the VxPx
motif15,17,18. To understand how these mutations could lead to PRCD-associated disease,
we will transfect hRPE1 cells to study the protein stability, localization, membrane
association, and palmitoylation status. Additionally, we will also utilize subretinal injection
of these constructs to determine how these mutations affect the fate of PRCD protein
stability, localization and interaction with binding partner rhodopsin. Little is known
regarding the importance of these structural domains in PRCD. Polybasic regions have
been shown to strengthen interactions between proteins and membranes through
electrostatic interactions, while the VxPx motif has been studied thoroughly in rhodopsin
as a ciliary targeting motif19-22. It is not known whether PRCD requires this polybasic
region for proper OS disc membrane association or the VxPx motif for proper trafficking
and localization to the OS. Studying these mutations would help to clarify the need for
these structural domains in PRCD function and localization.
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Due to the inconspicuous nature of PRCD because of its small size, it took many years
for scientists to link disease-causing mutations to the small gene which codes for PRCD
protein. Although several animal models with mutations in or loss of PRCD have been
characterized, still very little is known about PRCD and its significant contribution to
maintenance of retinal health. Studies, including ours, have demonstrated that PRCD
plays an important role in OS disc morphogenesis. We know that discs do not form
properly and rhodopsin incorporation into disc membranes is not consistently maintained
in the absence of PRCD, yet the specific requirement for PRCD in regard to its
mechanistic role in OS maintenance remains undiscovered. These proposed experiments
could provide crucial information required to uncover these answers.

4.2 Conclusions and Future Directions – Chapter 3
Many studies have demonstrated the unique requirement of the b2-subunit of the retinal
Na+, K+-ATPase (ATP1B2) in maintenance of retinal health. Not only do half of all
photoreceptors degenerate in the absence of ATP1B2 by P17, but other b-subunit
isoforms have demonstrated the inability to compensate for loss of ATP1B2, as
demonstrated in a b1/b2 knock-in animal model where ATP1B1 is expressed in place of
ATP1B223,24. In fact, western blot analysis of retinal lysate from animals lacking ATP1B2
also demonstrates severe reduction of the sole a-subunit isoform in photoreceptors
(ATP1A3), suggesting loss of Na+, K+-ATPase from photoreceptors altogether. The asubunit of the Na+, K+-ATPase is known to be responsible for the enzymatic activity of the
ion pump and the b-subunit has been shown to be responsible for maturation and
trafficking of the holoenzyme to the plasma membrane25. However, very little is known
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regarding the role of the b-subunit, and specifically of the b2-subunit of the Na+, K+ATPase in the retina.

Apart from its role as part of the ion pump, ATP1B2 has recently been shown to serve as
a membrane anchor for retinoschisin-1 (RS1), a protein which is secreted by and works
to maintain synaptic connections between photoreceptors and bipolar cells26-31. Mutations
in RS1 have been linked to X-linked retinoschisis (XLRS), a blinding disorder which
mainly affects males and results in early macular degeneration. XLRS is specifically
characterized by splitting (or “schisis”) of layers of the retina32-36. While it is possible that
the degeneration in the aforementioned b1/b2 knock-in could be explained by loss of
membrane anchorage of RS1 due to loss of ATP1B2, degeneration occurs more quickly
than retina lacking RS1 and no “schisis” is apparent, suggesting an important role for
ATP1B2 which is separate from its role as an ion pump and in membrane anchorage of
RS124,37. Therefore, it is likely that there is another role of ATP1B2 in the retina which has
not yet been identified.

In the 3rd chapter of this dissertation, our lab used a myriad of techniques to determine
that ATP1B2 undergoes S-palmitoylation on its 10th amino acid (Cys10). Not only is Cys10
heavily conserved within ATP1B2 across several mammalian species, it is unique to the
b2-subunit isoform. All post-translational modifications of the b-subunit isoforms of the
Na+, K+-ATPase have proven to be important in their maturation and unique cellular
functions, including the number of N-linked glycosylations25,38. Therefore, it is highly likely
that post-translational lipid modification of ATP1B2 by S-palmitoylation plays a role in its
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intrinsic function within the retina. Interestingly, preliminary studies in our lab demonstrate
that endogenous ATP1B2 is only palmitoylated in retina, brain, and skeletal muscle, all of
which are very metabolically active tissues (Fig. 4.1). We plan to isolate additional tissue
to analyze by acyl-PEG exchange to determine whether palmitoylation status of ATP1B2
is exclusive to these aforementioned tissues.

Figure 4.1. Palmitoylation status of ATP1B2 in
various tissues was determined using acyl-RAC and
western blot. T = total, U = unbound, E = elute,
NH2OH = hydroxylamine

Unfortunately, elucidating the role of ATP1B2 has proven challenging, as acyl-RAC
analysis of hRPE1 cells transfected with our HA-tagged WT-ATP1B2 plasmid constructs
(ATP1B2-HA) shows only slight palmitoylation of our ectopically expressed ATP1B2
protein. Similarly, subretinal injection of our plasmid constructs in WT retina only yields a
small palmitoylated fraction of ATP1B2-HA, though a large amount of endogenous
ATP1B2 clearly undergoes palmitoylation. We believe that there are several explanations
for this. First, it is highly possible that the machinery in the retina required for
palmitoylation of ATP1B2 is occupied by and preferentially chooses endogenously
expressed ATP1B2. Another possible explanation is that transfection of our plasmid
constructs by subretinal injection may not be reaching the appropriate retinal cell types

139

housing the machinery required to palmitoylate ATP1B2, as our constructs are not
photoreceptor-specific. Therefore, in cell culture or subretinal injection, transfection of
ATP1B2 into cells which do not endogenously express and palmitoylate ATP1B2 could
lack the required palmitoylation machinery. Finally, it is possible that the C-terminal HAtag could alter the structure of ATP1B2, impeding interactions between the proper DHHC
motif-containing palmitoyl acyltransferase (DHHC-PAT) enzyme and HA-tagged ATP1B2.

In order to understand the role of palmitoylation of ATP1B2, our first goal is to establish
and standardize an expression system where WT ATP1B2 is palmitoylated properly in
cell culture. Once we do this, we can easily compare our HA-tagged WT ATP1B2
construct with our non-palmitoylated ATP1B2-C10A mutant. To determine the proper
system for expression of palmitoylated ATP1B2, we first plan to transfect hRPE1 cells
with a plasmid construct expressing untagged WT ATP1B2 and evaluate its palmitoylation
status using acyl-RAC. This experiment will tell us if the HA tag is altering the structure of
ATP1B2, preventing access to DHHC-PATs. As hRPE1 cells only express the a1- and
b1- subunits of the Na+, K+-ATPase, we can use a commercially available antibody
against ATP1B2 for western blot analysis of our acyl-RAC samples without worrying
about endogenous expression of the protein. If the palmitoylation status of untagged
ATP1B2 remains low, we plan to purchase commercially available cell lines which
endogenously express ATP1B2, such as the human retinoblastoma cell lines WERI-Rb1 or Y79. As these retina-derived cells express ATP1B2 and ATP1A3, it is likely that they
would contain the proper DHHC-PATs required for palmitoylation of ATP1B2, so we could
evaluate the palmitoylation status of our HA-tagged WT and C10A ATP1B2 constructs
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using acyl-RAC. Alternatively, we could attempt to co-transfect hRPE1 cells with different
DHHC-PATs in order to determine which DHHC isoforms enhance palmitoylation of
ATP1B2, though 23 isoforms have been identified39. Once we establish a proper
expression system of palmitoylated WT ATP1B2, we plan to transfect cells with our WT
and mutant C10A ATP1B2 constructs. After confirming loss of palmitoylation by a C10A
mutation in ATP1B2 in those cells by acyl-RAC, we plan to investigate the importance of
palmitoylation, through evaluation of differences in protein-protein interactions between
WT or mutant ATP1B2 and its a3-subunit, as well as Na+, K+-ATPase localization and
membrane association.

As mentioned in the discussion of chapter 3, many tissues express a third subunit which
has been shown to associate with the a- and b- subunits of the Na+, K+-ATPase, known
as the g-subunit25. Seven different isoforms of the g-subunit have been identified and are
expressed in a tissue-specific manner (FXYD1-7), all of which have been implicated in
modulation of Na+,K+-ATPase activity40,41. In the retina, no g-subunit of the Na+, K+ATPase has yet been identified. Due to the large number of energy-dependent processes
in the retina, such as phototransduction, neurotransmitter release, and intracellular
protein trafficking, and hyperpolarization/depolarization, it is unexpected that the retina
would not utilize an extra level of Na+, K+-ATPase modulation. One of our lab’s
hypotheses is that palmitoylation of ATP1B2 contributes an extra level of regulation to
Na+,K+-ATPase activity in the retina42. The reversible nature of palmitoyl lipid
modifications give rise to a dynamic role through palmitoylation and depalmitoylation of a
protein. To determine whether palmitoylation of ATP1B2 influences ion pump activity, we
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would compare Na+,K+-ATPase activity between transfected cells expressing
palmitoylated HA-tagged WT and non-palmitoylated mutant ATP1B2-C10A constructs.
We can measure Na+,K+-ATPase activity of transfected cell lysate using a commercially
available colorimetric or fluorometric ATPase activity assay which allows for quantification
of ATP (https://www.abcam.com/atp-assay-kit-colorimetricfluorometric-ab83355.html).

Though the specific requirement for the b2-subunit of the Na+, K+-ATPase in the retina
remains uncertain, it is clear that retinal health is dependent on its expression. Further
work must be done to determine how loss of ATP1B2 from the retina influences
photoreceptor and inner retinal neuron function. Due to the high amount of ATP utilization
by the Na+, K+-ATPase and the number of energy-demanding processes which take place
in the retina, it is unusual that this metabolically active tissue lacks the g-subunit of the
Na+, K+-ATPase, an additional regulator of Na+, K+-ATPase ATP consumption. Further
investigation of palmitoylation of ATP1B2 will lead to elucidation of the unique
requirement of ATP1B2 in the retina, as well as its role in Na+, K+-ATPase pump activity.
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